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ABSTRACT
Hawkinson, Ann C. Experimental Infection of Jamaican Fruit Bats (Artibeus
jamaicensis) with Tacaribe virus. Published Doctor of Philosophy
dissertation, University of Northern Colorado, 2011.
Virtually nothing is known about the immunology and virus-host interactions of
bats (order Chiroptera). The discovery of bats as reservoirs or potential reservoirs of
many important human and veterinary pathogens such as ebolaviruses and Nipah and
Hendra viruses, has recently sparked an interest in bat immunology. Bats may become
persistently infected with viruses without signs of pathology, while human infections
often lead to severe disease and death. It is unknown how this type of virus-host
interaction is established in bats. This project began to examine the immune systems
and virus-host interactions in two species of bats. Tacaribe virus was isolated from two
species of Artibeus bats in the early 1960s and belongs to a group of arenaviruses that
cause the South American hemorrhagic fevers. Tacaribe virus is not known to cause
natural human infections. It would be highly unusual for Tacaribe virus to be hosted by
Artibeus bats, as it would be the only arenavirus, for which the host is known, that does
not have a rodent host. Discovery of the specific immune characteristics that allow bats
to become persistently infected with many pathogens may offer medically important
information for the treatment of human infections. Cytokine genes from Seba’s shorttailed fruit bat (Carollia perspicillata), were cloned, sequenced, and compared to
orthologous mammalian sequences. It was hypothesized that bat cytokine genes are
similar to the cytokine genes of other mammals. Jamaican fruit bats (Artibeus
jamaicensis) were experimentally infected with Tacaribe virus and it was hypothesized
that they would become persistently infected; however, this did not occur. These results
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indicate that bat cytokine genes are highly conserved with respect to other mammalian
cytokine sequences, and that Jamaican fruit bats do not become persistently infected
with Tacaribe virus.
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CHAPTER I

INTRODUCTION
Bats (order Chiroptera) represent nearly one fifth of all known species of
mammals [1], yet many aspects of their biology are poorly understood [2]. The ecology
and general biology of bats has been well studied, but there is relatively little known
about bat immune systems or the immune responses of bats to infectious agents. For
many years, rabies virus has been the most studied microbe of bat disease ecology [3-5]
[2]. It is only more recently that bats have been identified as reservoirs or potential
reservoirs of other important human and veterinary pathogens [2, 6]. Among these are
SARS CoV-like coronaviruses [7-9], Nipah and Hendra paramyxoviruses [10, 11],
lyssaviruses [12, 13], and Marburg and ebolaviruses [14, 15].
In some instances, viruses may cause persistent infection without producing
recognizable pathology. The establishment of persistent infections with little or no signs
of pathology could have contributed to bats being underappreciated as reservoirs of
many viruses [2]. Understanding how bat immune systems engage viruses or how many
viruses evade sterilizing host immune responses in bats will require further investigation.
It is suspected that the ability of bats to become persistently infected with viruses could
be due to distinct differences in bat cytokine genes and the expression of immune genes
during infection.
Characteristics of bat immune systems have not been previously studied
because methods to do so did not exist. Another problem with studying virus-host
interactions in bats and some viruses they are thought to host, is that many of these
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viruses are potential human pathogens that must be handled at biosafety level 3 or 4
(BSL3 or BSL4) [2]. Increased biosafety precautions make experimentation substantially
more difficult.
This project was initiated to develop immunologic and virologic methods in bats,
currently absent in infectious disease research. This project has largely been modeled
after work that had previously been conducted on a hantavirus/deer mouse project [1619]. Hantaviruses are rodent- or shrew-borne viruses, and some have the ability to
cause serious illness in humans. Sin Nombre virus (SNV) is a hantavirus that is hosted
by deer mice (Peromyscus maniculatus), which become persistently infected with SNV
without developing pathology. However, human infections with SNV and other
hantaviruses can cause hantavirus cardiopulmonary syndrome (HCPS). This illness is a
cytokine-mediated immunopathology [20-24]. Some researchers are investigating
possible differences between deer mouse and human immune responses to the viruses
[17, 25]. It is thought that deer mice and SNV have coevolved resulting in the evolution
of virus-host coexistence by allowing the virus to establish a persistent infection without
causing disease or immunopathology in the host. If the mechanisms by which this
interaction takes place can be identified, they may offer a potential solution for avoiding
the immunopathology that is experienced with human infections [17, 21, 25]. Thus, a
similar rationale underpins this study on bats and their viruses.
The examination of bat immune systems and immune responses is important on
several levels. First, immunology, virus-host interactions, and disease ecology is an
area of bat biology that has received little attention. Such examination could offer
information about a previously unexplored area of bat biology.
Second, there is high probability that the examination of bat immune systems
might offer important biomedical information about how bats avoid severe disease and
immunopathology that develops in humans. It is important to characterize the genetics
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and activity of bat immune responses as well as the complex virus-host interactions that
occur to better understand and control the emergence of viruses that are known or
suspected to be hosted by bats [26].
This project has focused on examining immune genes and virus-host interactions
in Seba’s short-tailed fruit bats (Carollia perspicillata) and Jamaican fruit bats (Artibeus
jamaicensis). Captive colonies of these bat species held at the University of Northern
Colorado were used in these studies.
A project to clone and characterize cytokine genes of Seba’s short-tailed fruit bat
was initiated to begin the process of characterizing bat immune systems. Cytokines are
hormone-like proteins that are used to mediate local immune responses. Actions of
cytokines can be inflammatory [23, 27, 28], anti-inflammatory [29], or can act to
modulate the development and actions of immune cells and tissues [30-32].
Characterization of bat cytokine genes is an important step in understanding the
immunological relationship between viruses and their bat hosts.
If bats act as reservoirs of specific viruses, the establishment of persistent
infections would seem likely. An investigation of the interaction between Jamaican fruit
bats and Tacaribe virus was initiated to begin identifying the underlying mechanisms that
govern non-pathogenic infections of reservoirs. Tacaribe virus (TCRV) is a New World
arenavirus that is not known to cause natural human infections and can be manipulated
at BSL2 [33, 34]. Other New World arenaviruses include Junín, Machupo, Sabia,
Guanarito, and Chapare viruses, which cause Argentine hemorrhagic fever (HF),
Bolivian HF, Brazilian HF, Venezuelan HF, and an as yet unnamed hemorrhagic fever
respectively [35-38]. These New World arenaviruses are extremely virulent in humans
and experimental work with them must be performed at BSL4.
Other New World arenaviruses such as Tacaribe, Oliveros, and Pichinde viruses
are not human pathogens [38, 39]. All arenaviruses, for which the reservoir is known,
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are hosted by rodent species [40]. Previously, researchers believed that TCRV had a
unique non-rodent host species [33].
Tacaribe virus, was originally isolated from two species of Artibeus bats. On two
separate occasions, TCRV was isolated from captured Jamaican fruit bats; however, it is
unknown if this species is a reservoir of TCRV, or if infections were due to incidental
infection [33, 34]. This finding is of interest for several reasons. If bats were found to be
the host of TCRV, it would be the first arenavirus to have a non-rodent host. Second,
TCRV may establish persistent infections in Jamaican fruit bats, and examination of this
interaction may help identify characteristics of bat immune responses that allow for the
establishment of persistent infections without the development of pathology. A third
aspect that is attractive about TCRV is that it is a New World arenavirus that can be
manipulated at BSL2 making it easier to manipulate during experimentation. It is also
possible that TCRV could be used as a disease model for South American hemorrhagic
fevers (SAHF). Development of a Tacaribe arenavirus infection model has recently
been suggested using interferon (IFN) receptor deficient mice [41, 42]. Results from the
work presented in this dissertation suggest that TCRV infection in Jamaican fruit bats
could be used as a disease model (Unpublished results).
Specific Aims And Hypotheses
The first aim of this project was to clone and sequence immune genes and
immune-related transcription factors from Seba’s short-tailed fruit bat. Cloning and
characterization of immune genes from this bat species has not previously been done.
Developing these types of immunologic methods will allow the characterization of bat
immune systems.
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Specific aim 1: To determine if bat immune genes, specifically cytokine genes,
are similar to orthologous mammalian sequences, and to begin characterizing
chiropteran immune systems. Seba’s short-tailed fruit bats from the University of
Northern Colorado were used in this project. Spleens were collected from
euthanized bats and used for ribonucleic acid (RNA) extraction, complimentary
deoxyribonucleic acid (cDNA) synthesis and amplification of cytokine genes.
Cytokine-specific primers were used to amplify the genes.
H1: Chiropteran cytokine gene sequences are similar to
orthologous mammalian sequences.
The second aim of this project was to determine if Jamaican fruit bats can
become persistently infected with Tacaribe virus (TCRV) and to examine tissue tropism.
Persistent infections would be expected if Jamaican fruit bats were the natural reservoir.
Specific aim 2: To determine if Jamaican fruit bats can become persistently
infected with TCRV. Jamaican fruit bats were experimentally infected with TCRV
at the biosafety level (BSL) 3 unit at Colorado State University. Blood samples
were collected for virus isolation, and neutralizing antibody tests. Oral and rectal
swabs were collected to determine if virus shedding occurred. Collected tissues
were used for polymerase chain reaction (PCR), virus isolation and
immunohistochemistry (IHC) to determine virus tropism.
H2: Jamaican fruit bats are reservoirs of Tacaribe virus.
The third aim of this study was to develop a rapid field test for detection of TCRV
specific antibody. This is not a hypothesis driven experiment, but rather work to develop
an immunoassay that is greatly needed for research with TCRV. A rapid field-test for
TCRV would allow for quick identification of naturally infected animals in wild
populations, as well as confirmation of infection and seroconversion of experimentally
infected animals.
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Specific aim 3: To develop a serological test by cloning and expressing an
antigen of the TCRV nucleocapsid that will be recognized by TCRV-specific
antibodies. The nucleocapsid gene was cloned and placed into an expression
vector. Protein expression and purification could allow the nucleocapsid antigen
to be used in an enzyme immunoassay, such as a protein A/G horseradish
peroxidase conjugate.
The findings from this research project indicate that Seba’s short-tailed fruit bat
cytokine genes are highly conserved with respect to orthologous mammalian cytokine
genes. Results also indicate that Jamaican fruit bats do not become persistently infected
with TCRV, and that they likely are not the natural reservoir of TCRV. A large portion of
the TCRV nucleocapsid gene has been cloned into an expression vector, and it is
believed that expression of this protein will be possible. This study is an important step
toward the general characterization of bat immune systems, the development of
immunologic methods in bats, as well as a step toward developing an immunological
model for host-pathogen interactions in bats.
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CHAPTER II

REVIEW OF LITERATURE
General Bat Ecology
Bats (Order Chiroptera) comprise nearly one fifth of the approximately 5416
documented species of mammals. Bats inhabit all continents of the world except
Antarctica, and they are important assets to their ecosystems [2, 43]. Bats are unique
because they are the only mammals that exhibit true powered flight, and they are able fly
and forage at night [43, 44]. Bats exhibit a wide range of body sizes, with the smallest
bat weighing only 1.5 grams and the largest bat weighing as much as 1.5 kilograms [43,
44] and some species may live as long as 30 years. Bats employ a wide variety of
roosting behaviors and mating systems and typically produce one to two offspring per
year. Some bats enter torpor (a shortened form of hibernation) to conserve energy
when resources are limited or temperatures are cold, while others migrate [43-45].
Bats are divided into two suborders; Microchiroptera, which is comprised of 17
families and approximately 1030 species [1], and Megachiroptera, which is comprised of
one family (Pteropodidae) and approximately 186 species [1]. The suborder
Microchiroptera encompasses the echolocating bats. While many of these bats are
insectivorous, there are diverse feeding ecologies seen within this suborder, which
includes bats that feed on fruit, nectar, pollen, blood, small vertebrates, insects, and
arthropods [43, 45]. Bats in the family Phyllostomidae exhibit many of these diverse
feeding ecologies [43]. The work presented in this dissertation focused on two species
of bats from the suborder Microchiroptera and the family Phyllostomidae. Bats in the
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suborder Megachiroptera are known as the Old World fruit bats or flying foxes, and eat
mostly fruit and nectar. Megachiropterans do not utilize complex echolocation, but
instead rely on vision and olfaction to locate food sources [43].
The diverse feeding ecologies of bats play several important ecological roles.
Species of insectivorous bats aid in the control of insects [46, 47]. Fruit and polleneating species of bats are important in the pollination and seed dispersal of many plant
species [48, 49]. In some cases, the interaction between bats and plants can be
specific. Jamaican fruit bats have been found to be valuable seed dispersers of fig
seeds in Panama [49]. Orii’s flying fox (Pteropus dasymallus inopinatus) has been found
to be an important seed disperser of several native plant species on Oki-nawa-jima
Island, Japan. In this case, Orii’s flying fox may be the only seed disperser on the island
that is capable of moving the large fruits produced by some plants [50]. The pollination
and seed dispersal of plants by bats is beneficial to plant species by providing a means
for plants to maintain their populations [48-50]. It has also been found that bats may
play an important role in re-seeding fragmented or disturbed areas of forests [51].
These pollination and seed dispersal activities are beneficial to fruit-eating mammals
including humans by providing them with food sources [49]. Bats also produce guano
which has important uses in agriculture and pharmaceuticals [2, 52].
Bat Immunology
Although bat ecology and general bat biology are areas that have been
extensively researched, many aspects of bat biology and physiology are poorly
understood. Specifically, bat immunology and disease ecology have previously received
little attention [2, 6]. This significant area of bat biology needs to be examined to fully
understand how bats interact with the ecosystem.
In some cases, it is possible that bat populations could be experiencing disease
and mass-mortality from infection with microorganisms. An example of this is white nose
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syndrome (WNS), which has caused severe declines in some bat populations in North
America [53]. It is thought that WNS is caused by infection with the fungus Geomyces
destructans [53, 54]. Symptoms include fungal growth on the nose, ears, and wing
membranes, leading to severe physiological dysfunction [53, 55]. Bats have long been
studied as reservoirs of rabies virus, which has occasionally been documented causing
mortality in bat populations [5]. However, this is not always the case as bats sometimes
appear to be persistently infected with rabies without developing symptoms [5, 56].
While rabies research in bats has received much attention and there is extensive
literature available on bats and lyssaviruses [2, 5], it is only within the past decade that
bats have been discovered as reservoirs or potential reservoirs of many other important
human and veterinary pathogens [2, 8, 10, 14, 57]. Among the list of viruses known or
suspected to be hosted by bats are lyssaviruses other than rabies [12, 13], ebolaviruses
[14, 58], Marburg virus [15, 59], Nipah virus and Hendra virus [10, 11], and Severe acute
respiratory syndrome coronavirus (SARS CoV)-like viruses [7-9].
In some cases, it appears viruses may establish persistent infections in bats
without causing pathology. This is intriguing because human infections with many of
these viruses can cause severe disease and death. Whether considering a bat
pathogen, or a virus that may establish a persistent infection in bats without pathology,
little is known about bat immune systems or virus-host interactions in bats. It is
necessary to investigate this portion of bat physiology, biology and ecology to fully
understand all aspects of bat biology. Although examining bat immune systems is
essential to a comprehensive understanding of bat biology, the examination of bats as
reservoir hosts to viruses can be somewhat controversial. This is because identifying
bats as reservoirs of virulent human and veterinary pathogens may led to their
persecution and eradication [60]. This reaction could be contraindicated, as loss of
biodiversity has also been proposed as a mechanism by which infectious diseases
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emerge and spread [61]. Just as human population growth and encroachment into
previously uninhabited territory are drivers of disease emergence, loss of bats as hosts
to many of these viruses may led to increased numbers of human and veterinary
outbreaks [61-63]. For these reasons, and the ecological importance of bats,
examination of bat immunology and virus-host interactions while protecting them from
persecution must be conducted [60]. Examining the immune systems of bats as well as
the virus-host interactions that occur may clarify some aspects of bat biology and offer
insight as to how persistent infections are accomplished. This could provide important
information about how to treat human infections caused by many deadly viruses.
Researchers have begun to examine some of the biological characteristics of
bats with respect to their ability to act as reservoirs of many viruses [60, 64].
Characteristics that have been identified as potential factors influencing the ability of
bats to act as reservoirs or sources of emerging diseases include the use of torpor, the
ability to fly long distances, genetics of immune genes, and the regulation of immune
genes during infection [64, 65]. This review will discuss virus-host interactions,
immunologic methods that exist for examining these interactions, what is known about
bat immunology, and viruses that have been isolated from species of bats. This review
also aims to explain the need for examining bats as reservoirs and how the research
project presented in this dissertation approaches this need.
Persistent Infections
An examination of the relationship that exists between a virus and its natural host
is essential to understanding all aspects of a virus’ ecology. In many cases, a reservoir
host of a virus can become persistently infected and not develop disease [22, 66, 67]. A
virus must have a susceptible host to infect to persist in nature. If a virus were to cause
serious pathology or kill the natural host, it would not be advantageous for the virus or
host.
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On the other end of the spectrum, spillover infections into humans or other
species often cause serious disease. Humans and other non-reservoir species are
usually dead-end hosts [22, 66, 67].
It is not fully understood how persistent infections occur in host species, but
research has been successful in identifying some of the underlying mechanisms.
Researchers have investigated several aspects of virus-host interactions including
activity and regulation of immune genes and immune cells during infection, virus tropism,
viral evasion strategies, and viral replication strategies [66, 68]. Some of this work has
been performed in cell culture, while other researchers have explored experimental
infections. Coevolution between virus and host has also been suggested as a potential
reason for which viruses do not cause disease in the natural reservoir [67]. Examples of
interactions where persistent infections are established in the natural reservoir include
hantaviruses and arenaviruses and their rodent hosts. Human infections with many of
these viruses led to serious disease and possibly death.
Hantaviruses
In North America, the deer mouse can become persistently infected with Sin
Nombre virus (SNV) (Family Bunyaviridae, genus Hantavirus) without signs of pathology
[22]. Deer mice can be persistently infected for long periods of time, and the virus can
be spread and maintained from one population of deer mice to another [69]. Infected
deer mice can shed infectious virus in urine, feces, and saliva. When humans come in
contact with infectious products, the virus is contracted through the lungs, leading to
hantavirus cardiopulmonary syndrome (HCPS) or hemorrhagic fever with renal
syndrome [20, 21, 25, 70]. This interaction has led researchers to investigate the
underlying molecular and cellular mechanisms that allow for the accomplishment of
persistent infections in the rodent host.
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Arenaviruses
Arenaviruses are another example of viruses that cause persistent infections in
the host species, yet cause serious disease in spillover infections. Arenaviruses, for
which the host is known, are rodent-borne viruses [67, 71, 72]. Arenaviruses such as
Junín, Machupo, and Guanarito viruses cause South American hemorrhagic fevers
(SAHF) in humans, and are hosted by the drylands vesper mouse (Calomys
musculinus), the large vesper mouse (Calomys callosus), and the short-tailed cane
mouse (Zygodontomys brevicauda), respectively [38, 67, 71]. Persistent, yet
asymptomatic infections are established in the rodent hosts [67, 73]. Experimental
inoculations of the short-tailed cane mouse with Guanarito virus have shown that
persistent infections are established and that the cane mouse is the natural reservoir of
Guanarito virus [73]. Infected rodents shed virus in secretions including urine, feces,
and saliva, and when humans come in contact with these secretions, serious disease
can ensue [38]. Researchers have examined the interaction between some
arenaviruses and the rodent hosts in much the same way that the interaction between
SNV and the deer mouse was investigated. This research has led to the discovery of
some of the mechanisms by which persistent infections occur in rodents [74-77].
It appears that interactions between many viruses and the natural hosts may
offer information about avoiding the development of serious disease in human infections.
For this reason, it is important to investigate how these interactions occur. For some
viruses, researchers have developed immunologic methods to investigate the complex
virus-host interaction.

13
Methods Used To Examine
Persistent Infections
Hantaviruses
Cytokine genes encode polypeptides that are largely responsible for mediation of
the immune response. Cytokines are chemical signals that can be secreted or released
from several different types of immune cells to mitigate different microbial threats. Many
researchers have focused on cloning and characterization of the cytokine genes as a
way of examining the immune systems of host species [78-80]. This allows for the
examination of the immune system on the genetic level and for comparison to other
mammalian cytokine gene sequences. Cytokines such as granulocyte macrophagecolony stimulating factor (GM-CSF), tumor necrosis factor (TNF), interleukin-10 (IL-10),
and interleukin-23a (IL-23a) have specific activities in the immune response and can
mediate immune cell stimulation, inflammation and immune cell chemotaxis, downregulation of the immune response, and the initiation of the adaptive immune response
[29-31, 81, 82].
In SNV infection in deer mice, researchers have been investigating the
mechanisms by which persistent infections are accomplished by characterizing deer
mouse immune genes and examining immune responses during infection. Deer mouse
cytokine genes have been cloned, sequenced and compared to orthologous mammalian
sequences in an attempt to identify any possible differences in the genetic sequences.
The results of these projects largely agree that deer mouse cytokine genes are highly
conserved with other mammalian cytokine genes [19, 80]. With no identifiable
differences between the genetics of the immune genes, researchers believe that the
difference in disease progression could lie within the regulation of cytokines and the
behavior of immune cells during infection [17, 23, 80].
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Bone marrow and T cell culture parameters have been developed for the deer
mouse [18, 83]. These methods have allowed for the detailed examination of the cellular
and molecular characteristics of immune genes and cells of the deer mouse [18, 83].
These methods have been helpful in the characterization of deer mouse T cell
responses and development of other immune cells in response to SNV. More recent
studies on the deer mouse and SNV using these methods have found that regulatory T
cells expressing the cytokine TGFβ1 may be important for down-regulation and control
of immunopathology in the deer mouse [17].
Arenaviruses
Methods that have been used to investigate arenavirus infections in rodent hosts
are very similar to the methods described for SNV and the deer mouse. Many studies
examining persistence of arenaviruses in rodents are performed using lymphocytic
choriomeningitis virus (LCMV), which was the first arenavirus to be discovered [75, 84].
A study performed in 1936 utilized experimental infections of white lab mice and wild
mice to describe the mode of transmission of LCMV in mouse populations and the length
of persistence of viral infection [75]. Results from this experiment indicated that
infectious virus was shed in the urine and nasal secretions. Researchers also found that
mice were typically infected before or shortly after birth with the route of exposure likely
being the nasal mucosa [75]. The length of persistence in infected individuals was
observed to be as long as 15 months. It was concluded that an immunocompromised
status, like that of a neonate, is necessary for LCMV to evade clearance by the immune
system and establish a persistent infection [75].
Virus tropism of persistent arenavirus infection was examined using LCMV and in
situ hybridization [84]. Neonatal mice were experimentally infected with LCMV and were
euthanized after establishment of persistent infections. Tissue samples were fixed in
buffered formalin and placed in paraffin blocks. Tissue sections were then sliced and
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placed onto slides for examination. In situ hybridization was performed using a 35Slabeled DNA probe that was complementary to a portion of the S segment of the LCMV
genome. Hybridization was then visualized by exposing the slides to high-resolution
film. Film was then developed and slides were counter-stained with haematoxylin and
eosin to visualize, and were observed using microscopy. The results of this study
indicated that virus was present in many tissues of infected mice including the brain,
lung, liver, kidney, pancreas, thyroid, thymus, lymph nodes, testes, bladder, and salivary
glands [84]. This study and others performed before it showed that mice infected with
LCMV develop persistent viremia [84, 85].
More recent studies with LCMV have focused on specific mechanisms that allow
LCMV to evade a sterilizing host immune response. A study performed in 1997
examined the use of neutralizing antibody to prevent the establishment of persistent
LCMV infections in mice [86]. The results showed that neutralizing antibodies did
prevent the development of persistent infections in immunocompetent and
immunocompromised mice, including neonates. These results further support the
findings that arenaviruses must establish persistent infections in rodent hosts when they
are young and not yet immunocompetent [86].
Animal models
Another approach to examining the difference between viral infection of the
natural reservoir and spillover infections is to examine an animal model that exhibits
similar symptoms to human disease. Hantaviruses like SNV and Maporal virus (MAPV)
are asymptomatically carried by the natural rodent reservoirs. However, researchers
found that when MAPV was experimentally inoculated into Syrian golden hamsters
(Mesocricetus auratus) it caused pathology similar to the disease that develops in
human cases of HCPS [21]. This insight has allowed researchers to examine MAPV
infection of golden hamsters as a disease model for human HCPS [21]. A disease
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model has also been developed using Andes virus (ANDV) in the Syrian golden hamster
[25]. An animal disease model offers researchers the ability to experimentally examine
the interaction that occurs during acute infection to identify factors that contribute to
disease progression.
Viral evasion strategies
Infectious agents that have the ability to persist in host species without pathology
generally have genes that allow them to evade host immune responses. Some of the
viral genes that help viruses persist can suppress the immune functions of specific cells
by causing the blockage of antigen presentation [87]. Other viruses are able to produce
proteins that allow cytokine escape by binding and inactivating host cytokines[87].
Some viruses also use cytokine and chemokine mimicry by producing proteins that
closely resemble host cytokines and chemokines, but the viral proteins do not have the
same biological activity [87-90]. By subverting host immune responses, viruses are able
to avoid clearance and persist in the host. Examining viruses for viral evasion strategies
is allows for characterizing the virus-host interaction that leads to persistent infections.
As was described for persistent arenavirus infections in mice, some viruses avoid
immune clearance by infecting immunocompromised individuals [86]. Also, the
nucleoprotein of LCMV and other arenaviruses can be antagonistic of the type I IFN
response [74]. In this interaction, arenavirus nucleoproteins were found to block
interferon response factor-3 (IRF-3), a transcription factor that leads to signaling events
and eventually type I IFN production in infected cells. This has been suggested as a
mechanism by which arenaviruses evade host immune responses and are able to
establish persistence [74]. Similar findings have been made in New World hantaviruses
such as SNV and ANDV. The nucleocapsid proteins and glycoprotein precursors of
these viruses were found to inhibit IFN-β induction and the downstream signaling
pathways [91].
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In cell culture, Hendra and Nipah viruses have been identified as encoding
proteins that interfere with STAT1 transcription factor. This viral evasion strategy allows
the viruses to disrupt signaling events leading to the release of type I IFN which is
important in cellular immune responses [92, 93]. This finding is of particular interest in
terms of bat immunology, as specific species of megabats have been identified as
reservoirs of these viruses [94, 95].
Virus-host coevolution
Research has indicated that many viruses and their reservoir hosts have
coevolved over time [38, 67, 96]. Interactions over millions of years could account for
infection without disease.
Phylogenetic studies of viruses and host species have been conducted for
arenaviruses and hantaviruses. The results of these analyses show a very tight
association between specific viruses and hosts [38, 67, 71, 97]. Phylogenetic trees
constructed for the New World arenaviruses show noticeable similarity to the
phylogenetic trees constructed for rodents found in the same geographic region. These
results support the hypothesis that viruses and the natural hosts have been interacting
and cospeciating for many years [67].
Presence of viral gene segments in host genomes are thought to represent an
ancient interaction between virus and host that, over time, led to the incorporation of viral
genes into host genomes. This field is referred to as paleovirology [96]. Phylogenetic
studies and next generation gene sequencing methods have been used to study the
possible coevolution of filoviruses and mammals.
Phylogenetic tree construction allowed researchers to identify possible paleoviral
elements in small mammals, including bats, insectivores, and rodents [96]. While these
types of studies do not explain specific mechanisms employed to establish persistent
infections, they do help reveal that the ability to act as reservoir to a virus without
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developing disease is not an easily or quickly acquired characteristic. Understanding the
history of virus-host interactions might help characterize the complexity of the
relationship.
Immunologic Methods In Bats
Characteristics of bat immune systems and the mechanisms by which viruses
establish persistent infections in bats have not been extensively studied because
methods to do so have only recently been developed. In many cases, methods that
currently exist to characterize immune responses in other mammals may be useful in
examining bats, but likely need to be optimized for use in bat species. Using methods
that have previously been established for immunologic research in other mammals is the
approach that some researchers have taken to bat immunology.
Due to the enormous amount of research that has been performed on rabies and
related lyssavirus infections in bats, there are well-developed methods for detecting
rabies infection and examining the virus-host interaction that occurs [12, 56, 98, 99].
Methods for detecting other infections in bats could be developed by using methods
similar to those used to diagnose rabies, and in some cases, these tests have already
been developed [57, 100-102]. Some of the methods available to detect viral infection in
bats include immunofluorescence and immunohistochemistry, neutralizing antibody
tests, enzyme linked immunosorbent assay, and PCR [12, 98, 99].
Immunofluorescence and
immunohistochemistry
Accurately testing for some viral infections such as rabies and related
lyssaviruses may require tissue collection from the organism. Tissues can be examined
for the presence of viral nucleocapsid using techniques such as direct
immunofluorescence assay (IFA) or fluorescent antibody tests (FAT) [12, 99, 103, 104].
Histopathological and cytological examinations can also be performed on tissue samples
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to detect rabies. These methods may require fixed tissue sections or cell culture, and
may vary in sensitivity. A study performed in 2003 tested the efficiency of FAT,
histopathology and cytological examinations for the detection of rabies [105]. The
authors prepared identical tissue samples for each method, and compared the ability of
each to accurately detect rabies virus. The study concluded that FAT is the most
sensitive technique followed by histopathology and then cytological examination [105].
Plaque assays can also be conducted to detect virus presence. Plaque assays
include the use of cell culture to detect the formation of plaque units due to activities of
virus. This technique is only useful if the virus is known to show cytopathic effect (CPE)
in cell culture [106]. While methods such as IFA, FAT, and plaque assays are useful in
different situations, they may take a considerable amount of time to complete.
Enzyme-linked immunosorbent
assay
Many researchers have begun to develop and use specific immunoassays such
as enzyme-linked immunosorbent assays (ELISA) [15, 107] This type of test is used to
identify specific antibodies to virus in serum samples (indirect ELISA) or the presence of
viral antigen (sandwich ELISA). One challenge to indirect ELISAs is that it is necessary
to develop virus specific antigens for each virus species. In these tests, viral antigen is
prepared and coated onto the wells of microtiter plates. Tests for many viruses have
previously been developed for detection of antibody in humans or other animals.
Developing many of these tests for use in bat research may require modification by
producing anti-bat immunoglobulins, which would be used as secondary detection
antibodies [15, 107].
ELISAs have been developed to detect the presence of lyssavirus-specific
antibodies in collected serum samples of bats [12]. The use of ELISA can make
screening processes and discovery of previously undetected viral infections much
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simpler and rapid than other methods [14, 59, 101, 108]. In 2001, a random tissue and
serum sampling of bats found in restaurants of Cambodian provinces was performed.
Serum, organs, and tissue samples were investigated using IFA, FAT, and ELISA [12].
This study was the first to identify anti-lyssavirus neutralizing antibodies in the serum of
Cambodian bats. This project was a random sampling and was not performed on bats
showing symptoms of rabies infection. Bats sampled in this project were seemingly
healthy, and therefore the authors conclude that the bats may be reservoirs of the
detected lyssavirus. The authors suggest that without previously causing mortality or
disease in bats, it could that this lyssavirus strain was previously undiscovered [12].
Subsequently, researchers have developed similar tests for detecting viral infection of
other viruses in bats including Nipah virus, ebolaviruses, and Marburg virus [14, 15, 100,
101, 107-109].
While ELISAs can be useful for detection of virus-specific antibody or viral
antigen, the length of time required to complete these assays can be extensive. Some
ELISAS may require up to 5 hours to complete. This makes rapid screening of
mammalian populations in the field difficult [16, 110]. More recent developments have
made it possible to perform rapid detection of antibodies to SNV during field studies.
Development of such rapid immunoassays allows for much faster identification of
infected rodents in the field without requiring transport of samples to a lab [16]. It is
likely that similar tests can be developed for use in screening both wild and
experimentally infected bats for presence of virus-specific antibody. The development of
a rapid field immunoassay for Tacaribe virus, which was isolated from the Jamaican fruit
bats in Port of Spain Trinidad (Unpublished observations) [33], is a current activity of this
dissertation work.
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Bactericidal activity and T-cell
mediated responses
Less specific tests including the measurement of bactericidal activity, and T cell
mediated responses to mitogenic challenge have also been employed to examine bat
immune systems [111]. Using these methods, one study aimed to examine the innate
and adaptive immune responses of wild caught bats in relation to the type of roost that
was utilized. In this study, female Brazilian free-tailed bats (Tadarida brasiliensis) were
caught and blood samples were taken. Whole blood samples were diluted and mixed
with bacterial samples, which were then plated out on trypticase soy agar plates. After
the plates were incubated, bactericidal load was calculated from colony counts. The
fewer bacterial colonies that were present after incubation indicated increased
bactericidal activity present in the blood sample. Captured bats were also examined for
T cell mediated immune activity by administering subcutaneous injections of
phytohaemagglutinin to stimulate leukocyte agglutination. Adaptive immune function was
measured by quantifying the amount of swelling that occurred at the site of infection after
a 12-hour period. Results indicated that there was a difference in the bacterial killing
ability and the T cell responses of bats at different roost sites. The researchers
concluded that immune responses and susceptibility to disease may be linked to
roosting ecology of bats [111].
Polymerase chain reaction
and gene sequencing
PCR is useful for detecting presence of virus in tissue samples and other
collected samples such as swabs, and real time PCR can be performed to quantify viral
load. While other techniques such as ELISA can be useful for detecting viral antigen or
virus-specific antibody, PCR techniques offer the possibility of gene sequencing to
confirm presence of virus. PCR requires viral RNA extraction, cDNA synthesis, and
amplification using virus specific primers. After amplification, gene sequencing should
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be performed to confirm identity of viral genes. In several studies, total RNA was
extracted from serum samples or organ samples of bats and screened by PCR for the
presence of infectious agents. This type of screening not only allows for the evaluation of
experimentally infected animals, but also the identification of reservoirs in broad
screening projects. This has led to the discovery of bats as potential reservoirs of novel
astroviruses, a reovirus, and a novel GBV-like flavivirus [112-114]. Other studies have
detected Marburg virus and Nipah virus in organs of sampled bats using similar methods
[100, 115].
Next generation sequencing technologies such as pyrosequencing have been
used to detect the presence of bat-borne viruses in collected guano samples [116].
Pyrosequencing technology sequences genes as DNA synthesis takes place by
detecting DNA polymerase activity with chemiluminescent enzymes. In one study, bat
guano samples were collected underneath bat roosts in Texas and California and viral
nucleic acids were extracted using QIAamp viral RNA extraction kits. Random primers
were then used on RNA samples to synthesize cDNA libraries and amplify genes.
Amplified PCR products were resolved on a 2% agarose gel and gel purified. PCR
products were then sequenced using pyrosequencing technology. Sequence contigs
were made using Sequencher software and basic local alignment search tool (BLAST)
analyses were performed. The BLAST results indicated that a large number of viral
genomes were present in the guano samples. The majority of detected viral sequences
were similar to eukaryotic viruses that infect insects. The second largest group of viral
sequences showed similarity to viruses that infect plants and fungi. The third largest
group of viral sequences showed similarity to viruses that infect mammals. While none
of the detected viral sequences showed similarity to any known human pathogen, some
viral sequences were identified from the Picornaviridae, Adenovridae, Poxviridae,
Astroviridae, and Coronaviridae viral families. It was concluded that many of the viruses
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identified in this study likely reflect the diet of the insectivorous bats that were screened.
PCR and gene sequence analysis can be helpful in large screening projects performed
to identify any possible viruses in species of bats [116].
In some cases, virus may be shed through the urine of infected bats, and the
capture and extraction of urine from bats without requiring euthanasia can be quite time
consuming [117]. An easier way of collecting bat urine samples was developed in 1999
while examining pteropid species of bats for occurrence of Nipah virus. The method
includes the use of large plastic sheets that are placed on the ground below the entrance
to the roosting place of bat populations. The plastic sheet collects the urine samples,
which then may be collected with sterile swabs for viral RNA extraction and PCR [117].
Multiple samples can be collected using this method, but it is possible that samples from
many different bats will be pooled together. This method may be applicable in detecting
viral infections in other bat species infected with other viruses.
The methods described above were used as a way to detect viral infection in
bats and other mammals. While the ability to detect current or past infection with viruses
is an important part of understanding disease ecology in bats, it is also necessary to
examine the characteristics and activity of bat immune systems.
As some of the more recent immunologic research in bats has shown, it is
possible that characteristics of bat immunology can be investigated using modified
methods that are commonly used in mammalian immunology [2]. In the past decade,
there have been advancements made in the field of bat immunology, and future
research may further foster this progression.
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Characterization Of Bat Immune
Genes and Antibodies
Bat cytokine genes
As was previously discussed, the examination of immune genes and related
transcription factors has helped researchers gain information about how the immune
systems of other mammals behave during infection [17]. Examination of bat immune
genes and transcription factors may help identify possible components of bat immune
systems that allow for viral persistence. Methods used to characterize the immune
system of deer mice and the virus-host interaction that occurs between deer mice and
SNV have been modified to examine the immune systems of bats [80]. Several cytokine
genes from Seba’s short-tailed fruit bat have been cloned and characterized using these
methods (Unpublished results). The methods and results of these studies will be
discussed in chapter three of this dissertation.
Bat immunoglobulin genes
Other studies have focused on the cloning and sequencing of bat
immunoglobulin (Ig) genes [118-120]. It was found that bat Ig genes are highly
conserved when compared to other mammalian Ig gene sequences [119]. Although no
significant sequence differences were identified, two studies have found that bat Ig
genes have a surprising amount of sequence diversity in the variable heavy chain
repertoire [118, 119]. It was suggested that this increased diversity in the variable heavy
region of bat Ig may be associated with the ability of bats to act as reservoirs of viruses.
It was also suggested that coevolutionary relationships between bats and viruses could
be a reason for this diversity [118].
Bat cluster of differentiation 4
The sequence of bat cluster of differentiation 4 (CD4) T cell receptors has also
been examined using PCR and sequencing analysis [120]. Spleen samples were
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collected from Egyptian fruit bats (Rousettus aegyptiacus) and total RNA was extracted.
cDNA synthesis was followed by PCR using CD4 specific primers. Amplified PCR
products were then sequenced. Bat CD4 sequence alignment with human, monkey,
mouse, cat, dog, rabbit, and pig CD4 sequences indicated that bat CD4 is conserved in
relation to other mammalian CD4. A few differences were identified between the bat
CD4 and human, monkey, and mouse CD4 sequences. These differences included a
lack of a cysteine residue, along with an 18 amino acid long insertion in the bat
sequence. The cysteine residue is involved in disulfide bond formation in the CD4
receptor. The lack of this cysteine residue could possibly interfere with the structure and
function of the CD4 receptor, but the authors did not consider these differences to be of
great importance because cat, dog, and pig CD4 sequences also lack the same cysteine
residue. The overall conclusion was that bat CD4 is highly similar to other mammalian
CD4 [120].
Bat signal transducers and
activators of transcription
STAT1 (signal transducers and activators of transcription factor-1) is a
transcription factor involved in signaling events associated with the type I IFN response.
One study examined STAT1 of the Egyptian fruit bat using cloning and sequencing
techniques. The activity of bat STAT1 was also investigated in cell culture using
immunofluorescence staining and confocal microscopy [121]. Results from these
studies indicate that the sequence of bat STAT1 is conserved with respect to other
mammalian STAT1 sequences, and that the function of bat STAT1 also appears to be
the same as other mammalian STAT1 [121].
The results from cloning and sequencing projects indicate that bats have immune
genes and related transcription factors that are very similar to other mammals. As in the
case of other virus-host interactions, including the deer mouse and SNV, these results
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have led researchers to suspect that the differences between bat and human infections
with many viruses may lie in the regulation of immune genes during infection. Some
researchers have focused attention on cell culture and experimental infections to
investigate this possibility.
Bat interferon and primary
cell culture
Some studies have examined the expression of bat interferon (IFN) genes in cell
culture. In these studies, researchers investigated bat IFN-α and IFN-β gene expression
from primary kidney and lung cells of the Egyptian fruit bat [122]. The authors were
interested in examining any differences in interferon expression or antiviral behavior
between bats and humans. Genomic DNA was extracted from fresh bat liver samples
and was used in the initial sequencing of the bat IFN-α and IFN-β genes. The authors
then examined expression of IFN mRNA from bat primary kidney and lung cells using
polyinosinic:polycytidylic acid (poly I:C) treatment to induce IFN expression from the
cells. Poly I:C is known to interact with toll-like receptor (TLR) 3 and induce signal
transduction events in response to antigens. Toll-like receptors are an important part of
activating the innate immune system. Supernatant containing bat type I IFN was
collected and placed into primary kidney and lung cell cultures to examine expression of
interferon in response to treatment with bat type I IFN. It was found that bat primary
kidney and lung cells behaved differently in response to the treatment with bat type I IFN
media. It appears that up-regulation of type I IFN will induce bat kidney cells to produce
more IFN, but this was not seen in the bat lung cells. The authors believe that
characterization of bat antiviral mechanisms is important in determining how some
animals, including bats, can act as asymptomatic carriers of infection. [122]
Methods used to examine filovirus infection using a line of primary bat cells has
recently been developed [123]. The cell line R06E was developed from fetal Egyptian
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fruit bat cells [124]. These fruit bats have recently identified as a reservoir of Marburg
virus. In this study, the R06E cell line was examined for the potential to be used in
experiments with Marburg virus. The researchers found that the R06E cell line was
highly susceptible to filovirus infection and they believe that use of these cells will be
beneficial in gaining information about how filoviruses interact with the natural reservoir.
This study suggests that the development of cell lines from bat species may be useful in
examining the virus-host interaction in vitro [123].
Experimental Infections
As was previously mentioned, experimental infections can also provide important
information about virus-host interactions. Experimental infections have been employed
for many viruses and the host species, and are also being used to examine the
interaction between bats and viruses that have been detected in or isolated from them.
A few examples include experimental infections with rabies, henipaviruses, and
filoviruses [125-127]. These studies will be discussed in later sections of this review.
Future methods
Other methods for characterizing bat immune systems and immune responses
that will require more work to develop include bone marrow and T cell culture, and the
development of better diagnostic techniques. Bone marrow cell and T cell culture
parameters have been established in non-model rodents including the deer mouse [18,
83]. It is possible these methods could be adapted and used to characterize the immune
responses of bats. The need for continued development of immunologic methods in
bats is reflected in the number of viruses that have been isolated from them.
Bats As Reservoirs
Rabies and related lyssaviruses
Historically, lyssaviruses, such as rabies, are commonly found in bat species
throughout the world. Rabies and rabies-like lyssaviruses have been the most studied
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bat viruses to date [128, 129]. Not only have lyssaviruses been identified in bats, but
there have also been documented spillover infections in other mammal species such as
foxes (Vulpes vulpes), skunks (Mephitis mephitis), martens (Martes foina) and even
humans. Susceptible species include almost all warm-blooded animals [99, 103, 104,
130].
Rabies and related lyssaviruses are in the family Rhabdoviridae and the genus
Lyssavirus. In this genus, there are seven known genotypes including rabies virus,
Australian bat lyssavirus, European bat lyssavirus 1, European bat lyssavirus 2,
Duvenhage virus, Lagos bat virus, and Mokola virus [5, 98, 131]. Bats are important
vectors for lyssaviruses with six out of the seven known genotypes having been
documented various species of bats [5]. Rabies virus has a worldwide distribution and is
found in a wide range of wild and domestic mammalian species including bats [130,
131]. Australian bat lyssavirus was found in fruit bats and was identified after causing
human cases of encephalitis [132]. European bat lyssaviruses 1 and 2 have been found
in insectivorous species of bats as well as other small wild mammals [99, 103, 104, 131].
Lagos bat virus has been found in cats, dogs, and shrews, as well as bats [131]. Mokola
virus was first isolated out of as species of shrew, and has been found in several cases
of domestic animal infections [131].
Human infections with rabies can usually be traced to physical contact, such as a
bite, from an infected bat or other mammal [133]. Cases of exposure where no contact
was experienced are very rare [134]. Natural infection with rabies causes death in the
majority of human infections, but rabies-specific neutralizing antibodies have been
detected in seemingly healthy bats [3, 56]. However, rabies and related lyssaviruses are
known to cause mortality in bat populations [5]. The mechanisms by which some bats
develop disease while others do not are unknown. The identification of bats as
reservoirs of these viruses, and the inconsistency in the outcome of bat infections with
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them, have inspired some researchers to screen bat populations to identify infected
individuals that may not be exhibiting symptoms. This type of approach has led to the
discovery of lyssavirus infection of bats in restaurants in Cambodia [12]. Experimental
infections of bats with rabies and related lyssaviruses have also been conducted to
examine the role of bats as reservoirs.
Big brown bats (Eptesicus fuscus) have been experimentally infected with
Eurasian bat lyssavirus strains to determine viral pathogenesis and tissue tropism of the
virus [127]. The authors of this study found that lyssavirus strains show tissue tropism
mainly in neuronal tissues with some virus being shed in the salivary glands up to 5 days
prior the onset of symptoms. The bats also showed no virus transmission to other
uninfected cage mates [127]. Another study used rabies virus variants to experimentally
infect Jamaican fruit bats to define disease progression and tissue tropism. Bats were
inoculated with different strains of rabies virus and monitored for symptoms. Moribund
bats were euthanized and tissue samples were examined using immunoperoxidasestaining techniques. The authors found that disease progression in bats infected with
different virus variants was very similar in most cases [133].
Researchers have also performed experimental infections with rabies virus in
bats to examine the ability of bats to either develop disease, or clear the virus [56]. In
one study, big brown bats were experimentally infected three times. After each round of
infections, bats either cleared the virus and survived, or developed disease and died.
Bats that cleared the virus after each infection were re-infected. The results indicated
that repeated exposure and infection with rabies virus in bat populations might contribute
to a reduced susceptibility to rabies. It was also suggested that the dose of virus that
bats are exposed to might play a role in the outcome of infection with lower dose
exposure possibly acting to immunize populations [56].
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While rabies and related lyssaviruses have been known as bat viruses for many
years, other viruses have been discovered in bats only more recently. Due to these
discoveries, studies with these viruses in bats are relatively new.
Henipaviruses
Hendra and Nipah viruses are in the family Paramyxoviridae and the genus
Henipavirus. They are closely related and cause severe febrile encephalitis in humans
with a high mortality rate [135]. An outbreak of Hendra virus was first identified in 1994 in
Hendra, Australia when 21 horses and two humans began showing symptoms of severe
respiratory disease and fever with a high fatality rate [136]. Upon first examination, the
virus was named equine morbillivirus, but was later named Hendra virus. Nipah virus,
was identified in Malaysia in late 1998 when domestic pigs and eventually humans
developed neurologic disease and fever [94]. At the time of the first outbreaks of these
viruses, the natural reservoir and route of exposure was unknown. Sequencing studies
provided viral classification and subsequent serological surveys that followed identified
the reservoir species of these viruses [94, 136].
After the initial outbreak of Hendra virus in 1994, researchers set out to identify
the natural reservoir of the virus. It was hypothesized the virus was hosted by a wild
mammal species and, thus, trapping programs were initiated. Serum samples from
many species were screened for the presence of antibody specific to Hendra virus, and
eventually several seropositive species of Australian flying foxes (genus Pteropus) were
identified [95]. Virus isolation was accomplished on RK13 cell cultures, and sequencing
confirmed Hendra virus infection. IFA staining showed that cell cultures were infected
with Hendra virus, and serology detected Hendra virus-specific antibody in serum
samples. These results indicated that certain species of flying foxes found in Australia
are the natural reservoir for Hendra virus [57]. Experimental Hendra virus infections
were performed on species of pteropid bats and results showed that bats became
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infected with the virus, and seroconverted. Histopathology of collected organ samples
showed limited pathology in bat tissues, and positive immunostaining of placental tissue
indicated that horizontal transmission of Hendra virus in bats is possible [137].
After the initial outbreak of Nipah virus in 1998, and its identification as a
paramyxovirus similar to Hendra, researchers began to search for the natural reservoir
[94]. Because Hendra virus had been isolated from species of pteropid bats,
investigators focused more attention on species of bats found in Malaysia. Serologic
studies sampled many species found in the area of the outbreak, and in five species of
bats Nipah-specific neutralizing antibodies were detected [108]. Isolation of Nipah virus
from urine samples and partially eaten fruit was performed using Vero cells, and
confirmed using IFA and virus sequencing. Vero cells, which are African green monkey
kidney epithelial cells, are typically used for virus isolation studies because they have a
disrupted type I IFN response making virus propagation easier. The results from the
Nipah virus study indicated that island flying foxes are one of the natural hosts of Nipah
virus [10].
Another 2002 study surveyed many species of Cambodian bats and found only
flying foxes to test seropositive for Nipah-specific antibody by ELISA. Serum and urine
samples were collected and used for ELISA and for virus isolation which was successful
in Vero E6 cells [100]. Vero E6 cells are a closely related lineage of Vero cells. In the
case of Hendra and Nipah viruses, pteropid species of fruit bats have been identified as
the natural reservoir. More recently, experimental infections of pteropid bats with Nipah
virus were performed. Similar to the results of experimental Hendra virus infections, it
was found that the bats seroconverted, developed subclinical infection, and were
intermittently shedding virus in urine. These results suggest that pteropid bats are
reservoirs of Nipah virus [102].
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Coronaviruses
Coronaviruses can cause respiratory and gastrointestinal diseases in humans
and other mammals. Severe acute respiratory syndrome coronavirus (SARS CoV)
emerged in 2002 in China [138]. The reservoir of the virus was unknown when the
outbreak of SARS first occurred. However, palm civets (Paguma larvata) and other
animals sold in live animal markets were implicated as reservoirs [8, 138]. Surveillance
studies on wildlife populations in China eventually led to the discovery of SARS CoV-like
coronaviruses in bats [7, 8, 139, 140]. A SARS CoV-like virus was discovered in Chinese
horseshoe bats during a study in 2004 and 2005 [7]. Several species of animals were
captured during this study, and blood, anal swabs, and nasopharyngeal swabs were
collected. Samples were tested for coronavirus RNA using PCR and sequencing. Three
different coronaviruses were identified. With this discovery found only in bats, the
authors suggested that bats with roosting behavior be closely monitored for transmission
of coronavirus-like disease into human populations [7]. Studies surveying for the
presence of SARS CoV-like viruses have also been performed in North America [9],
South America [141], northern Europe [142], and the Philippines [126]. Each of these
studies was successful in the detection of coronaviruses in bat species.
Filoviruses
Ebolaviruses and Marburg virus belong to the family Filoviridae and can cause
outbreaks of hemorrhagic fevers in Africa. [15]. The source of outbreaks of Ebolaviruses
and Marburg virus were previously unknown. Following an outbreak of Ebola Zaire in
1995, researchers performed experimental infections of plants and animals with Ebola
Zaire virus. It was found that species of insectivorous bats and fruit-eating bats
developed high titer viremia upon infection.
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While this did not provide evidence that bats could be possible reservoirs of
filoviruses, it did show susceptibility [143]. More recent serologic evidence has
suggested that ebolaviruses and Marburg virus may be hosted by species of fruit bats
[14, 59].
A study performed between 2001 and 2005 tested many species of mammals for
ebolavirus infection [14]. The authors of this study were able to detect ebolavirusspecific IgG in the serum of three bat species. Viral RNA was also detected in organ
samples using viral gene amplification by PCR. Each species of bat that was
determined to be positive for ebolavirus infection has a home range that spans the areas
where previous ebolavirus outbreaks (in human populations) have been encountered in
Africa. These results suggested that bats are a candidate for the natural reservoir of
ebolaviruses [14].
Another study tested bats in the rainforests of Angola for Marburg virus [59]. The
authors believed that an outbreak of Marburg virus in Angola in 2005 came from bats
living in the rainforests of Gabon. Tissue samples were collected from 10 bat species
and examined for viral RNA using PCR. Serum samples were also collected and tested
for antibody to Marburg virus. Of the 10 species examined, only one species was PCR
positive for Marburg infection. These results suggested that the Egyptian fruit bat
(Rousettus aegyptiacus) may be the natural reservoir of the virus and that filoviruses
may exhibit host species specificity [59].
Other studies have been successful in identifying that Marburg and ebolaviruses
both circulate in populations of Egyptian fruit bats in Gabon [101]. In a study performed
in 2009, isolation of Marburg virus was accomplished from Egyptian fruit bats on several
occasions. Results of this study indicated that long-term virus circulation occurs in fruit
bat populations [107]. A similar study performed in 2010, showed long-term survival of a
tree-roosting fruit bat (Eidolon helvum) that had been naturally infected with an
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ebolavirus and Lagos Bat virus. These data indicated that this bat species may also act
as a reservoir for these viruses [144]. As was previously discussed, a close
coevolutionary relationship may account for the lack of disease progression in bats with
filoviruses [96].
Flaviviruses
West Nile virus (WNV), widely know as a bird virus, can cause serious disease in
some mammals. WNV-specific antibodies were identified in bats in 1999 in the U.S
[145]. Experimental infections with WNV had previously been limited to birds [146], but
a study in 2005 examined the ability of North American bats to serve as amplifying hosts
for WNV [106]. The authors also examined infected bats for clinical signs of disease.
Serum samples were collected from wild species and tested using a blocking enzyme
immunoassay to assess natural infection rate. Experimental infections were performed
at BSL3 using bats that were captured in the field. Bats were observed for symptoms of
disease and were euthanized on days 1 through 6 and day 14 and 40 post infection.
Serum samples were collected and tested for neutralizing antibodies using plaquereduction neutralization tests. Seven big brown bats showed viremia during the
experiment while other species showed no signs of infection. Oral swabs showed no
viral RNA and virus isolation was unsuccessful. The authors of this study concluded that
North American species of bats only developed low-level viremia for a short period of
time. While these species can become infected with WNV, they are unlikely amplifying
hosts of the virus [106].
A more recent discovery was the detection of a novel flavivirus in Old World fruit bats
[112]. The authors of this study began a wide survey of bat species in attempt to identify
known or possibly unknown microorganisms. Serum samples were collected from
several Indian flying foxes (Pteropus giganteus) in Bangladesh, and screened using
pyrosequencing technology. The authors were able to identify a novel Flavivirus, GBV-
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D. The abbreviation GB came from the initials of a surgeon who was acutely infected
with hepatitis. Experimental inoculations of tamarins (Saguinus abiatus) with serum from
the surgeon led to hepatitis [147, 148]. In the 1990s, Flaviviruses GBV-A and GBV-B
were identified from infected tamarins after several virus passages [147, 148]. GBV-D
virus was the first GBV-like virus to be detected in species of bats [112].
Astroviruses
Astroviruses can cause gastroenteritis in many species of mammals including
humans. Recently, astroviruses have been detected in species of bats in China [114].
During a study in Hong Kong, nine species of bats were sampled on two occasions and
tested for presence of astrovirus. The first sampling took place in different wild habitats
in Hong Kong, and the second sampling took place in a cave roost. Bats were captured,
identified, and oral and rectal swabs were collected in viral transport medium. Viral RNA
was extracted from the swabs and PCR was performed using astrovirus specific primers.
Cloning and sequencing allowed the authors to perform a phylogenetic analysis of the
astroviruses obtained from the swabs. It was found that 46% of collected rectal swabs
were positive for astrovirus and 8% of the oral swabs were positive. Out of the nine
species of bats examined, astroviruses were detected in seven. Phylogenetic analysis
of the bat astroviruses showed that 72 out of 77 bat astrovirus genes cluster together.
This discovery denoted a novel group of astroviruses. The authors suggest that mark
and recapture studies be used to examine the possibility of viral persistence [114].
Herpesviruses
Herpesviruses are a group of DNA viruses that can cause latent infections in
humans and other mammals. Examples include cytomegalovirus (CMV), Epstein-Barr
virus (EBV), and varicella zoster virus (VZV). CMV is classified as a betaherpesvirus,
EBV is classified as a gammaherpesvirus, and VZV is classified as an alphaherpesvirus.
The first discovery of a bat-related herpesvirus was in 1996 when CMV was
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encountered in the submandibular glands of two little brown bats (Myotis lucifugus)
[149]. Tissue sections of little brown bat salivary glands were being examined by
electron microscopy when CMV particles were discovered. This was the fourth
mammalian order to be discovered with CMV in the salivary glands [149]. Other studies
have utilized PCR to survey species of bats for presence of herpesviruses.
In 2007, seven gammaherpesviruses and one betaherpesvirus were discovered
in eight bat species in Germany using a herpesvirus PCR assay. Healthy, moribund, and
dead bats were collected and used in the study. Lung tissues and other organ samples
were collected and examined using histopathology and PCR. Virus was detected using
primers that were specific for herpesvirus DNA polymerase. Sequence alignments and
phylogenetic analyses showed that the newly discovered bat herpesviruses were related
to known gammaherpesviruses, but are novel [150].
Due to the discovery of novel herpesviruses in bats, other projects were initiated
to screen additional species of bats for presence of herpesviruses. Alphaherpesviruses
have been detected in phyllostomid and pteropid bats in Cambodia and Madagascar
[151]. Throat swabs were collected from several species of bats and herpesviruses
were detected using PCR and sequencing analysis. This study was the first to identify
alphaherpesviruses in bats, as well as herpesviruses in bats of the Pteropodidae and
Phyllostomidae families [151].
Novel gammaherpesviruses and novel betaherpesviruses have since been
discovered in bats the Philippines and Japan using direct sequencing technology and a
rapid determination system of viral RNA sequences [152, 153]. Bats are now
considered natural reservoirs of herpesviruses [151].
Other bat viruses
Three viruses have been detected in Seba's short-tailed fruit bats. These include
an unspecified betaretrovirus, Venezuelan equine encephalitis virus (VEEV) and a group
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1 coronavirus [141, 154, 155]. It is unknown if the short-tailed fruit bat is a reservoir for
these viruses, or if infection is incidental. VEEV was first isolated in Venezuela during
an equine outbreak in the 1930s [155]. VEEV has the ability to cause severe symptoms
in horses and humans. VEEV-specific antibodies had previously been discovered in
Artibeus bats in Guatemala [156]. After this discovery, studies were conducted to
examine natural and experimental infections of several species of Neotropical bats with
VEEV variants. It was found that a species of Carollia bats (C. subrufa) developed high
titer viremia with no apparent pathology [155, 157, 158]. This, again, suggests that bats
may become persistently infected with virus and serve as a maintenance host.
Bacteria And Other Microbes
While bats are reservoirs or potential reservoirs for many viruses, they are also
known to interact with other types of microbes. In some cases they become acutely
infected or may act as reservoirs of bacterial and fungal microorganisms.
Leptospirosis
Leptospira is a urine-borne bacterial pathogen that has the ability to cause
leptospirosis in humans and other mammals. Complications from this disease include an
enlarged spleen, jaundice and inflammation of the kidneys. A serological study of
Australian flying foxes was conducted to identify any exposure of these bats to
leptospiral species of bacteria [159]. This survey of leptospiral infection in pteropid bats
was prompted by an increase in the number of reported human infections. Serologic
results from this study found that not only are flying foxes sufficient hosts for Leptospira,
they may play an important roll in the establishment of new serotypes of bacteria, as well
as the natural transmission cycle of this bacteria in Australia [159].
Histoplasmosis
Histoplasmosis is a fungal disease caused by Histoplasma capsulatum. It has the
ability to cause the human illness known as acute pulmonary histoplasmosis [160].
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Histoplasmosis is often associated with bats due to the contraction of the disease after
visiting caves [161, 162]. This fungus has been isolated from samples of soil as well as
bat guano in caves and rural work places [163]. Presence of Histoplasma capsulatum
was also detected in the intestinal tract of a Hairy slit-faced bat (Nycteris hispida) [163].
Although the natural reservoir for this fungus is not known these isolations indicate that
bats do interact with this fungus and could be aiding in the transmission of this disease
[161-163].
White nose syndrome
White-nose syndrome (WNS) is a fungal disease that is negatively affecting
some bat populations. The fungus Geomyces destructans is thought to cause WNS.
The fungus grows in the epidermis and dermis of the nose, ears, and wing membranes
of hibernating bats [53-55]. Hibernating bats infected with the fungus present with an
accumulation of white fungal growth on the muzzles and wing membranes, but there is
no inflammation associated with the infection [53, 55]. Examination of bat tissues shows
that this fungus penetrates hair follicles and sebaceous glands and causes serious
damage to the wing membranes [55, 164]. Infected bats have been observed using fat
reserves at a much faster rate and coming out of hibernation in the middle of winter [53,
54, 165]. Researchers have placed the fungus in the Geomyces genus using gene
sequencing and phylogenetic methods [54]. Isolation of this fungus from collected bat
tissues has been accomplished on dextrose agar. Laboratory propagation and
investigation of the fungus indicates that it grows best at low temperatures such as those
that may be found in hibernation chambers of bats. It has been suggested that bats may
also have the disadvantage of experiencing decreased immune activity during
hibernation [54].
WNS was first discovered in 2006 in New York State and has since caused the
death of many thousands of bats [165]. White nose syndrome has been observed to
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spread quickly and has now been detected in bat populations in other northeastern
areas of the U.S. and Canada [165]. White nose syndrome is clearly a pathogen to bats
and if the spread of this disease is not stopped, the effects could be catastrophic for
some bat populations. As previously discussed, bats play an important role in the
ecosystems in which they live, and severe declines in bat populations could cause
dramatic changes in the ecosystem [53, 165]. More research is needed to characterize
the interaction between bats and this fungus, and to identify possible ways to avoid
devastation of even more bat populations.
Arenaviruses
While it is not surprising that bats may be the reservoir of some viruses, it is
intriguing that an arenavirus, Tacaribe virus (TCRV), has only been isolated from bats
[33]. This is because arenaviruses, for which the hosts are known, are rodent-borne
viruses. Isolation of TCRV from Artibeus species of bats has led many to believe that
these bats are the natural reservoir. If this were confirmed, TCRV would be the only
arenavirus to have a non-rodent host.
Arenaviruses belong to the family Arenaviridae and the genus Arenavirus. The
name comes from the Latin word arena, which means “sand” or “grains of sand.” This
refers to the appearance of ribosomes inside of arenavirus virions [166]. Arenaviruses
are spherical in shape, enveloped and have a single-strand, ambisense RNA genome
[167]. Arenaviruses have two gene segments, the large (L) segment and the small (s)
segment. The large gene segment encodes an RNA-dependent RNA polymerase and a
zinc-binding protein called RING finger protein, Z [35]. The small segment encodes the
nucleocapsid protein and a glycoprotein precursor [35, 168, 169].
Arenaviruses are assigned to two categories, the Lassa virus complex (Old
World), and the Tacaribe virus complex (New World). The Lassa virus complex includes
Lassa virus, found in Africa, which is the etiologic agent of Lassa fever in humans,
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Lymphocytic Choriomeningitis virus, which can cause aseptic meningitis in humans, and
Lujo virus, which causes hemorrhagic fever in humans [35, 37, 75, 84, 170]. The
Tacaribe virus complex includes Junín, Machupo, Sabia, Guanarito, and Chapare
viruses, which cause Argentine hemorrhagic fever (HF), Bolivian HF, Brazilian HF,
Venezuelan HF, and an as yet unnamed hemorrhagic fever respectively [35-38]. Some
of these viruses are endemic to the area of the world after which they were named [171].
TCRV is also included in this group, but is unique in the sense that it is not known to
cause natural human infection. There have been several laboratory-acquired infections
reported, which only caused mild febrile illnesses. Also, out of many serologic tests
performed on bat handlers in Trinidad, only one tested positive for neutralizing antibody
to TCRV [34].
Arenaviruses can establish persistent infections in cultures of mammalian cells
as well as rodent hosts [40, 67, 71, 77, 172]. Many arenaviruses can infect mammalian
cell culture with little to no noticeable cytopathic effect [173]. It is largely unknown how
persistence is established in cell culture or in the mammalian hosts, but is has been
suggested that the presence of interfering particles (IP) that are released by the host
cells are involved in establishing persistent infections. IP are viral particles that are
missing some or all of the viral genome [77, 174]. The nucleoprotein of many
arenaviruses is antigenic, and also acts as an antagonist of the type I interferon
response [74]. The exception to this is that TCRV does not inhibit activation of beta
interferon or IRF 3 in infected cells [74]. It has also been suggested that macrophages
may be the target for virus replication for some arenaviruses such as Junín virus. Virus
replication was greatly slowed in macrophages of mice that had been previously
vaccinated against Junín virus [173]. These aspects could contribute to establishment of
persistent infections.
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Isolation of Tacaribe virus
In the early 1960s, Tacaribe virus was isolated from two species of Artibeus bats
(A. jamaicensis and A. lituratus), during a rabies surveillance program in Port of Spain,
Trinidad [33]. Research was conducted at the Trinidad Regional Virus Laboratory
(TRVL). The project examined diseased bats that had been brought in by residents of
the area, as well as bats that were netted in different areas around the island of Trinidad.
Jamaican fruit bats are in the suborder Microchiroptera and the family
Phyllostomidae. These bats are found in tropical regions of South America, the
Caribbean Islands, the Florida Keys, and Central America. On average, adult Jamaican
fruit bats weigh 42 gm and have a wingspan of 45 cm. Average body length is 10 cm
[175]. Jamaican fruit bats are fruit-eating generalists and fig specialists [49, 175]. They
exhibit harem-breeding behavior and females typically produce one or two offspring per
year. Gestation is approximately 150 days and young bats are carried by the mother for
about 40 days after birth [175].
During research with TCRV, virus isolation was successful using the original
collected bat tissues that had been homogenized and injected into suckling mice. The
strain of TCRV that was isolated from bats is TRVL-11573 from A lituratus. Bats
naturally infected with TCRV were described as showing similar symptoms as bats
infected with rabies virus. Symptoms included perching in odd locations or solitarily,
tremors, and unkempt coats [33]. It was recorded at the time that TCRV was also
isolated from a mosquito pool. This isolation was the only one of its kind and the authors
have considered the possibility that the samples may have been contaminated. TCRV
has not been isolated from other mosquito pools. In an attempt to identify other
mammals that might be infected with TCRV, over 2300 native and migratory birds and
2000 native mammals (mainly rodents) were tested for TCRV antibody. None were
seropositive, and virus isolation was not accomplished [33].
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Downs et al. performed experimental infections [33] using intramuscular
injections of TCRV strain 11573 to examine the susceptibility of Artibeus bats to TCRV.
Weanling mouse intracranial LD50 was found to be 10-2 per 0.03 mL. One group of A.
jamaicensis and A. lituratus were experimentally infected with 828 weanling mouse LD50
and a second group received a virus inoculum of 10,000 weanling mouse LD50 [33].
These experimental infections led to inconclusive results. A total of 33 wild-caught
Jamaican fruit bats were inoculated, and only one bat in the experiment showed postinoculation immunity to TCRV. From the organs collected from that bat, virus was
recovered from the salivary glands, spleen and liver. One weakness of this experiment
was that the authors did not control the experiment by pre-infection bleeds. This could
mean that the one bat that showed viral circulation could have already been infected in
the wild before it was captured. Due to this error, there is no way to determine if the
experimental infections were successful, or if the low incidence of infection was due to
the low dose that was administered through the muscle.
Between 1972 and 1974, serum samples were collected from 39 different
species of bats in Trinidad to identify viruses potentially carried by bats [176]. Antibodies
specific for TCRV were detected in Jamaican fruit bats using mouse neutralization tests.
Unfortunately, virus was not isolated and thus was not useful in determining current virus
activity [34].
Experimental infections with Tacaribe virus have been performed with mice and
guinea pigs, but no further bat studies had been performed since the initial isolation [42,
177]. It has been found that TCRV is lethal to newborn mice causing paralysis and
necrosis in the central nervous system. In adult mice, TCRV replication was only
observed in small amounts and was avirulent causing no notable pathogenesis [42].
TCRV has also been examined as a possible vaccine for Argentine hemorrhagic
fever [166]. TCRV is not known to cause serious disease in adult laboratory animals,
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and is thought to be unable to cause disease due to the inability of TCRV to antagonize
the type I IFN pathway [74]. Due to TCRV having less virulent qualities in many
laboratory animals and the fact that it is closely related to Junín virus (the etiologic agent
of Argentine hemorrhagic fever), TCRV was chosen as a possible vaccine candidate
[166, 178]. In this study, guinea pigs were experimentally infected with TCRV, and
subsequently challenged with Junín virus. The authors examined the rodents for viral
presence and tissue damage and found that no virus or antigen from Junín virus could
be detected using immunofluorescence at any stage of infection. No damage was
detected in the tissues that were collected. TCRV viral titers were found to peak between
7 to 10 days post infection and become undetectable around day 30-post infection.
Neutralizing antibodies that were cross protective to Junín virus were produced. These
results indicated that TCRV could possibly be used as a vaccine against Junín virus or
other dangerous arenaviruses [166].
That TCRV can be manipulated at BSL-2 and the ease with which it can be
propagated in Vero E6 cell culture makes it an attractive candidate as a New World
arenavirus model [41, 77]. TCRV has been found to be nonpathogenic in many
mammals, possibly due to its inability to antagonize the type I interferon response [74].
However, TCRV is closely related to viruses that cause South American hemorrhagic
fevers [38, 41]. It shares 70% amino acid identity to Junín virus [178] and while it is not
known to infect humans, or cause disease in many laboratory animals, more recent
findings indicate that it may offer the possibility for the development of a disease model
and the chance to identify a potential treatment for SAHF [41].
TCRV is also interesting because it is the only arenavirus that has been
suggested to have a non-rodent reservoir. This raises the question of whether TCRV is
truly a bat virus or if there is some unknown rodent-reservoir. In any case, TCRV is
important as a representative of a group of viruses that cause serious human
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hemorrhagic illnesses, and as a model which could possibly be used to study virus-host
interactions of persistently infected mammals [2, 171]. Much more research about the
virus and its interactions with potential host organisms is needed before we can fully
understand it.
Detection of arenavirus infection
Even though Tacaribe virus is not known to cause serious human illness, it is
closely related to other viruses that do [178]. The serious nature of SAHFs makes early
detection of arenavirus infection important in saving human lives. Tests for detection of
arenaviruses can help in the screening process of diseased humans as well as the
screening of rodent populations. In the past, diagnosis of an arenavirus infection
depended on the geographic location of the case, and the type of symptoms that were
experienced by the individuals [171]. Other, more specific diagnostic tools have been
developed to detect these infections.
There is currently a high-throughput real-time PCR assay that can be used for
detection and quantitation of TCRV [171]. Although this assay is specific for TCRV, the
authors believe that it can be used as a diagnostic model for other arenaviruses. This is
more sensitive than the TCID50 method of detection that is commonly used for
arenaviruses. The RT-PCR assay can be performed in approximately 2 hours which
gives another advantage of possibly diagnosing the patient before symptoms start to
manifest [171]. One problem with this assay is that it detects any viral RNA, whether the
virus is infectious or inactive.
Other diagnostic tools, such as sandwich ELISAs, have been developed for
many arenaviruses including TCRV [179]. These assays are used to detect viral antigen
in a sample rather than antibody to specific viruses. Indirect ELISAs, which screen for
the presence of virus-specific antibodies in serum samples, have been developed for
several arenaviruses, but many require the use of whole virus as an antigen and the
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production of species specific secondary antibodies [180, 181]. Immunoassays can
provide a faster way to monitor past and current infections in mammalian populations
and diagnose infection in humans. However, many of these assays may still require 3 to
5 hours to complete and the transport of serum samples back to the laboratory [16, 182].
The amount of time required to perform these tests and the need for species-specific
secondary antibodies are typically not conducive to rapid screening projects in the field.
Modification of enzyme immunoassays to decrease the amount of time required to
complete the assay has been shown to be effective [16, 110]. The development of a
rapid immunoassay for TCRV might be advantageous in screening wild and
experimentally infected animals.
While there has been and currently is progress in our understanding of bat
immunology, there is still a great need for advancements of screening techniques and
methods that can be used to characterize the immune systems and immune responses
of bats. Many microorganisms that have been detected in or isolated from bats have
been discussed in this review. However, it is likely that many other microorganisms, less
well known, or even unknown, have not been discussed. The research project presented
in the following chapters of this dissertation aims to address several aspects of bat
immunology and virus-host interactions.
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CHAPTER III

MOLECULAR AND PHYLOGENETIC CHARACTERIZATION
OF CYTOKINE GENES FROM SEBA’S SHORT-TAILED
FRUIT BAT (CAROLLIA PERSPICILLATA)
Abstract
Bats (order Chiroptera) represent nearly one fifth of all known species of
mammals, yet many aspects of bat biology are poorly understood. Bats of certain
species are well known reservoirs of rabies virus but within the past few years bats also
have been identified as reservoirs or potential reservoirs of several other important
human and livestock pathogens. Among these are severe acute respiratory syndrome
coronavirus, Nipah and Hendra paramyxoviruses, several lyssaviruses, and both
Marburg virus and ebolaviruses (filoviruses). In some instances, filoviruses may cause
persistent infection without recognized pathology in the bat host. Even though these are
medically important viruses, little is known as to how bat immune systems engage them
or how they might evade a sterilizing host immune response. Recently, a project was
initiated to research the immune systems of Seba’s short-tailed fruit bats, which may be
a reservoir for a newly discovered coronavirus. cDNAs of four cytokine genes; tumor
necrosis factor (TNF), interleukin-10 (IL-10), interleukin-23a, (IL-23a), and granulocyte
macrophage stimulating factor (GM-CSF) were cloned and sequenced. Sequence
analysis shows these genes are highly conserved with regard to orthologous sequences
and they provide some value for resolving phylogenetic relationships between mammals.

47
This work represents a first step in developing an infection and immunology model for a
New World arenavirus in bats.
Introduction
In recent years, several zoonotic viral disease agents have been isolated from or
detected in bats [2]. For some viruses, bats are known reservoir hosts, and for others
they are suspected reservoirs or incidental hosts. Hendra virus, hosted by pteropid bats
[57], was first identified from cases of fatal equine and human respiratory disease in
Australia [183]. Nipah virus, also hosted by pteropid bats [184], has been associated
with multiple outbreaks of human disease in Cambodia, Malaysia, India and Bangladesh,
with case-fatality rates as high as 70% [100]. Lyssaviruses, including rabies virus, have
been detected in bats throughout the world, except in Antarctica [131]. Severe acute
respiratory syndrome coronavirus (SARS-CoV)-like viruses have been detected in
Chinese horseshoe bats [7], and it is thought SARS-CoV is a direct descendent of these
bat-borne viruses. Recent serological and molecular evidence suggests that
ebolaviruses and Marburg virus are hosted by fruit bats in Africa [14]. While some
infected reservoir host bats may show pathology, others appear to be asymptomatic [6].
Currently, more than 90 viruses have been identified from or detected in bat tissues,
suggesting that bats are significantly underappreciated as hosts and vectors for human
pathogens. Studies evaluating immune competency of bats are only now beginning to
be conducted [118, 119, 121, 185, 186] and the emergence of cost-effective
transcriptome sequencing should permit rapid advances in developing tools for
assessing bat immune responses.
Three viruses have been detected in Seba's short-tailed fruit bats; an unspecified
betaretrovirus, Venezuelan equine encephalitis virus (VEEV) and a group 1 coronavirus
[141, 154, 155]. It is unknown whether bats of this species are reservoirs of these
viruses or whether infections were incidental. Because these bats range from central
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Mexico to southern Brazil [187], it is important to determine their possible role in
maintenance and dissemination of these and other viruses. For this reason, we have
begun a project to determine susceptibility of Seba’s short tailed fruits bats to certain
viruses.
Since the role of the host response is important in resistance and susceptibility, it
will be necessary to develop methods for evaluating immune responses in the species. It
is likely that some bats may become persistently infected without disease and that the
viruses have evolved immune evasion strategies. Cloning of partial sequences of four
cytokine genes from Seba’s short-tailed fruit bat: tumor necrosis factor (TNF),
interleukin-10 (IL-10), IL-23a, and granulocyte-macrophage colony stimulating factor
(GM-CSF) has been accomplished. Molecular and phylogenetic analyses of the
sequences are presented here.
Materials And Methods
Bats
The University of Northern Colorado (UNC) bat colony comprises neotropical fruit
bats of two species, Seba’s short-tailed fruit bats and Jamaican fruit bats. These are
maintained together in a 36 m3 room that allows unrestrained free flight of all individuals.
The colony has been closed for 16 years and is rabies virus-free; PCR screening of
rectal swab samples from 20 of these bats has failed to detect coronaviruses (K.
Holmes, pers. comm.). The bats have access to roosting areas in the form of ceilinghung baskets and various cloth drapes and are maintained under a light-cycle of
12L:12D. Ambient temperature is maintained between 20 and 25°C and humidity
between 50% and 70% by a computer-controlled HVAC system. Bats are fed daily at
midday with grueled apples, monkey chow (Harlan Teklad, Denver, CO), molasses,
nonfat dry milk, cherry gelatin with raisins, and fresh bananas. In addition, a variety of
other fruits, including mango, papaya, cantaloupe, banana, grapes, and watermelon, are
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provided in food trays and also arrayed on skewers throughout the room to stimulate
foraging behavior. For additional enrichment, artificial trees and vines are provided.
All procedures for the present work were approved by the University of Northern
Colorado Institutional Animal Care and Use Committee and were in compliance with the
USA Animal Welfare Act. Euthanasia was performed by respiratory hyperanesthesia
with isoflurane followed by thoracotomy.
Ribonucleic acid extraction
A single cell suspension of splenocytes was prepared by gentle disruption of
spleens between the ends of sterile frosted glass microscope slides. Red blood cells
were lysed with ACK Lysis Buffer (Cambrex Biosciences, East Rutherford, NJ) for 5 min
at room temperature followed by 3x wash in PBS (pH 7.4). Splenocytes were cultured in
5% fetal bovine serum (FBS) RPMI-1640 and activated in 2 µg/ml concanavalin A and 2
µg/ml and E. coli LPS (Sigma, St. Louis, MO) overnight at 37°C under 7% CO2. RNA
was extracted according to manufacturer’s instructions using the Serious RNA
PurificationTM RNA Cell kit (Gentra Systems, Minneapolis, MN) and aliquots were stored
at -70°C until used.
Reverse transcription-polymerase
chain reaction
RNA was reverse-transcribed using qScript TM cDNA synthesis kit (BioRad,
Hercules, CA, USA) using a mixture of random hexamers and oligo-dT primers. PCR
was performed using degenerate primers (Table 1, see page 64) with a PCR Core kit
(Qiagen, Valencia, CA). Amplification was initially performed using 35 cycles of 95°C for
30 seconds, annealing at 58°C for 30 seconds, and extension at 72°C for 1 minute.
After 35 cycles, samples were incubated at 72°C for 10 minutes and then held at 4°C.
For genes that failed to amplify with 58°C annealing, the annealing temperature was
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lowered to 50°C for the first five cycles, then at 58°C for 30 cycles. PCR products were
then resolved on a 1% agarose gel to verify amplification.
Cloning of polymerase chain reaction products
Amplicons were cloned into TOPO-TA Sequencing (Invitrogen, Carlsbad, CA)
vector according to the manufacturer’s directions. Vectors were then used to transform
competent DH5a E. coli cells that were then plated on LB/Amp. Several colonies were
chosen from each gene and screened by PCR to verify the correct plasmid insert.
Colony screening was performed by PCR (Promega 2x PCR Master Mix, Madison, WI)
with primers used for the original amplifications. Selected colonies were then incubated
overnight at 37°C in 4 mL of LB broth containing 50 µg/ml ampicillin. Plasmids were
purified using a Qiagen QIAprep spin Miniprep kit (Valencia, CA), and recovery was
verified using a 1% agarose gel.
Rapid amplification of complimentary
deoxyribose nucleic acid ends
Rapid amplification of cDNA ends (RACE) PCR was used to obtain additional 5’
and 3’ sequences of Seba’s short-tailed fruit bat IL-23a, IL-10, and GM-CSF genes. 5’
regions were extended for all three genes, but 3’ RACE fragments were not obtained.
RACE was performed using a SMART™ RACE cDNA Amplification kit (Clontech,
Mountain View, CA). Primers for RACE PCR were designed from conserved regions in
previously obtained sequences described in section 2.4. RACE primers are included in
Table 2 (see page 64).
Sequence analysis
Sequencing reactions were performed using T7 and T3 primers with Big Dye
Terminator (Applied Biosystems, Foster City, CA). Sequences were edited and contigs
built using Sequencher (GeneCodes, Ann Arbor, MI) and basic local alignment search
tool (BLAST) was used to identify genes. Amino acid alignments were made using
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orthologous cytokine sequences from human (Homo sapiens), chimpanzee (Pan
troglodytes), rhesus monkey (Macaca mulatta), domestic dog (Canis lupus familiaris),
domestic cat (Felis catus), and house mouse (Mus musculus). Accession numbers are
listed for each protein in Table 3 (see page 65). The CLUSTAL algorithm in MacVector
sequence analysis software (Cary, NC) was used to perform the alignments.
Consensus sequences are listed at the bottom of each alignment. Creation of a
consensus sequence required greater than 51% amino acid identity in a single position.
Bat sequences were deposited into GenBank (TNF, EF653909; GM-CSF, EF653911; IL23a, EU223817; IL-10, EF653910).
Phylogenetic analysis
Phylogenetic analyses were conducted using amino acid sequences collected
from Seba’s short-tailed fruit bat and orthologous sequences obtained from GenBank.
Orthologous sequences were obtained from a single representative of as many
taxonomic groups as possible. The following orthologous sequences were used (see
Table 3 on page 65 for GenBank accession numbers); TNF from human, chimpanzee,
rhesus monkey, domestic dog, domestic cat, house mouse, horse (Equus caballus),
cattle (Bos taurus), pig (Sus scrofa), and chicken (Gallus gallus); IL-10 from human,
chimpanzee, rhesus monkey, domestic dog, domestic cat, house mouse, horse, cattle,
pig, and chicken; IL-23a from human, chimpanzee, rhesus monkey, domestic dog,
domestic cat, house mouse, horse, cattle, pig, and platypus (Ornithorhynchus anatinus);
and GM-CSF from human, chimpanzee, rhesus monkey, domestic dog, domestic cat,
house mouse, horse, cattle, pig, and chicken.
All sequences were aligned using the CLUSTAL algorithm in MacVector
sequence analysis software. PAUP* 4.0b10 [188] was used to perform maximum
parsimony analyses for each region. All characters were weighted equally and the
exhaustive search procedure was used to determine the most parsimonious tree. Trees
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were rooted using chicken as an outgroup for GM-CSF, TNF, and IL-10, and platypus for
IL-23a. Chicken sequence was chosen as an outgroup for GM-CSF, TNF, and IL-10
because it was the only non-mammal sequence available for all of the genes. Platypus
was chosen as the outgroup sequence for IL-23a as the chicken sequence was not
available in GenBank and the platypus could serve as an unrelated outgroup. Support
for branching patterns were analyzed using a parsimony bootstrap procedure with 1000
replicates to. Parsimony bootstrapping is a statistical procedure that examines the
repeatability of the placement of sequences into specific clades that are created during
analysis.
Results
Strategy for cloning bat
cytokine genes
A degenerate PCR cloning strategy was adapted from methods previously used
with wild rodents [19, 80]. Orthologous sequences of several mammalian cytokine genes
were aligned and degenerate primer sets were designed (Table 1, see page 64). Total
RNA was extracted from concanavalin A and LPS-stimulated splenocytes to enhance
transcription of cytokine genes. PCR was then performed and amplicons were cloned
and sequenced. Translated bat sequences and orthologous sequences were aligned to
identify conserved amino acid regions and analyze phylogenetic relationships. The
numbering above each sequence alignment refers to the numbering of the bat
sequence.
Tumor necrosis factor
The cloned cDNA of Seba’s short-tailed fruit bat TNF was 675 nt and encodes
approximately 96% of the TNF coding region. The nucleotide sequence was translated
using MacVector’s default translation table and then aligned with orthologous
mammalian sequences. The nucleotide sequence encodes nearly all of the TNF
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polypeptide (226 residues) and exhibits 82% identity and 84% similarity to human TNF
(Figure 1, see page 59). The gene is highly conserved between species and shares a
nearly identical transmembrane domain with orthologous TNF which was predicted
based on amino acid alignments (residues 32-58) [189]. Serine residues at positions 83
and 84, the putative cleavage point for the release of soluble TNF homotrimer, appear to
be similar to those of human, chimpanzee, rhesus monkey, dog, cat, and mouse TNF.
The cysteine residues at positions 148 and 180 for intrachain disulfide bond formation
are conserved in this bat [190]. A conserved histidine is present in the bat sequence at
position 194, and is necessary for biological activity of TNF [191]. Residues L115, S165,
and E225 are involved in receptor interaction of TNF [192], and are conserved in Seba’s
short-tailed fruit bat polypeptide.
Interleukin-10
The cloned cDNA fragment of Seba’s short-tailed fruit bat IL-10 was 453 nt in
length and encodes approximately 80% of the IL-10 polypeptide (151 residues) (Figure
2, see page 60). The polypeptide has 78% identity and 84% similarity to the human IL10 sequence [193]. The amino acid residues for the first four helices are highly
conserved in the Seba’s short-tailed fruit bat sequence (helix A, residues 42-65; B, 7382; C, 84-106; D, 111-134) [194]. The sequence is incomplete for the fifth helix. The
four conserved cysteine residues that are responsible for interchain disulfide bonds [195]
are also present in the bat sequence.
Interleukin-23a
The cloned fragment of IL-23a was 594 nt and encodes nearly 95% of IL-23a
gene (Figure 3, see page 61). The nucleotide sequence encodes nearly all of the IL-10
polypeptide (197 residues) and exhibits approximately 74% identity and 81% similarity to
human IL-23a. The bat sequence contains all four cysteine residues that are involved in
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intrachain disulfide bonding (residues 48, 84, 88, and 100) and also includes all four
helices (helix A, residues 39-58; B, 98-121; C, 127-147; D, 166-196) [31].
Granulocyte macrophage-colony
stimulating factor
The nucleotide sequence for Seba’s short-tailed fruit bat GM-CSF gene is 290 nt
and encodes the first 96 residues (~69%) of the bat polypeptide. This region is highly
conserved with a 25-residue signal peptide present (L, residues 1-25, Figure 4, see page
62) and shares 71% identity and 78% similarity to human GM-CSF. The bat polypeptide
contains a partially conserved helix A that is involved in binding to the GM-CSF receptor
(A, residues 29-44) [19, 196, 197], which differs by 6 amino acids compared to the
mouse, and by 8 amino acids compared to the human sequences. The ß1 strand that is
involved in receptor binding in other species is also present in this sequence (residues
59-61). Helix B is highly conserved (B, residues 72-84), and a partial helix C is encoded
in the polypeptide (C, residues 91-97) [197]. The bat sequence also encodes a
conserved cysteine residue (residue 71) that is used for the intrachain disulfide bond
[196]. The paired cysteine is located near the C-terminus of the polypeptide in other
species and would be found in a region of the bat sequence that has not been cloned.
Phylogenetic analysis
The alignment of TNF sequences included a total of 246 characters, of which 190
were variable and 45 were parsimony informative. The alignment of IL-10 sequences
included a total of 188 characters, of which 128 were variable and 51 were parsimony
informative. The alignment of IL-23a sequences included a total of 235 characters, of
which 174 were variable and 39 were parsimony informative. The alignment of GM-CSF
sequences included a total of 156 characters, of which 124 were variable and 56 were
parsimony informative.

55
Analysis of the TNF data resulted in 5 equally parsimonious trees (C.I. = 0.9054;
R.I. = 0.5272; length = 349). Consistency index (C.I.) values and retention index (R.I.)
values measure relative amounts of homoplasy in a tree [198]. Length values indicate
the number of character state changes that were necessary to arrive at the cladistic
grouping shown on a tree. Fewer character state changes indicate that a tree is a better
fit for the data [198]. The consensus tree placed Seba’s short-tailed fruit bat as
unresolved at the base of tree with house mouse, horse, and chicken (Figure 5A, see
page 63). The bootstrap analysis strongly supported a clade with human, chimpanzee,
and rhesus monkey (99% bootstrap), with human and chimpanzee exhibiting a sister
relationship within that clade (71% bootstrap).
Analysis of the IL-10 data resulted in 2 equally parsimonious trees (C.I. = 0.8732;
R.I. = 0.6500; length = 276). The consensus tree placed Seba’s short-tailed fruit bat as
basal to a clade containing domestic dog and domestic cat (Figure 5B, see page 63).
However, bootstrap analysis did not support the placement of Seba’s short-tailed fruit
bat. The only clade that was strongly supported contains human, chimpanzee, and
rhesus monkey (96% bootstrap), with human and chimpanzee exhibiting a sister
relationship within that clade (96% bootstrap).
Analysis of the IL-23a data resulted in single most parsimonious tree (C.I. =
0.9313; R.I. = 0.6901; length = 320). Within the tree Seba’s short-tailed fruit bat was
placed basal to a clade containing all of the placental mammals except house mouse
(Figure 5C, see page 63). Bootstrap analysis strongly supported the clade grouping
Seba’s short-tailed fruit bat with all of the placental mammals except house mouse (92%
bootstrap) and the clade containing human, chimpanzee, and rhesus monkey (100%
bootstrap), with human and chimpanzee exhibiting a sister relationship within that clade
(91% bootstrap).
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Analysis of the GM-CSF data resulted in 2 equally parsimonious trees (C.I. =
0.8859; R.I. = 0.6264; length = 298). The consensus tree placed Seba’s short-tailed fruit
bat as unresolved relative to all of the mammals except for mouse, which was
unresolved at the base of the tree with chicken (Figure 5D, see page 63). The bootstrap
analysis strongly supported a clade with human, chimpanzee, and rhesus monkey
(100% bootstrap), with human and chimpanzee exhibiting a sister relationship within that
clade (71% bootstrap).
Discussion
Until recently, bats have been underappreciated as reservoir hosts for
pathogenic viruses. The relationships between bats and their viruses are poorly
understood. Many zoonotic viruses hosted by other mammals often establish persistent
infections without significant pathological consequences. Identification of the underlying
mechanisms governing non-pathogenic infections of reservoirs may provide clues to
virus ecology as well as pathogenesis of human diseases caused by many viruses [2,
87].
Laboratory models that could be used to understand the immunological
relationships between viruses and their bat hosts are being developed. Several cytokine
genes from bats have been successfully cloned and sequences show that they are
substantially conserved among known mammalian orthologs.
TNF is thought to play a prominent role in pathogenesis of many infectious
diseases, including hantavirus cardiopulmonary syndrome, dengue hemorrhagic fever
and dengue shock syndrome [199]. It is a chemotactic inflammatory cytokine secreted
by various immune cells and is expressed as a membrane-bound homotrimer that is
cleaved by a cellular protease imbedded in the plasma membrane; its release induces
inflammation by causing vascular leakage [28]. The sequence of TNF from Seba’s short-
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tailed fruit bat is highly similar to TNF of other species and, other than a three amino acid
deletion at positions 64-66, contains no unusual differences from those sequences.
IL-10 is a noncovalently-linked homodimer secreted by many cells, including
some regulatory T cell subsets, and is capable of suppressing inflammatory responses
[32, 200, 201]. Each monomer is composed of six alpha helices and four conserved
cysteine residues that are responsible for intrachain disulfide bond formation [194]. The
bat polypeptide also is highly similar to IL-10 from vertebrates of other species,
especially within the functional domains.
IL-23a is in the interleukin-12 family and is co-expressed with IL-12p40 to form a
disulfide-linked heterodimer [31]. It is secreted from human and mouse dendritic cells
generated in the presence of GM-CSF and IL-4, can induce IFNγ responses and
promote proliferation of memory T cells in mice [202]. It is important for initiation of the
adaptive immune response to some infections. The bat polypeptide is highly similar
within domains to IL-23a of other mammalian species; however, it possesses a three
amino acid insertion (GEK) at positions 68-70, between helices A and B, a region with
unrecognized biological significance.
GM-CSF is a glycoprotein that can stimulate the growth and differentiation of
many immune cells, including bone marrow stem cells [203, 204]. It is secreted by a
variety of cells, including Th1 cells, controls the activities of a variety of phagocytic cells,
is an important stimulator for the growth and development of immune cells, and is
routinely used for in vitro propagation of dendritic cells from bone marrow progenitors
[205]. Although the sequence of Seba’s short-tailed fruit bat GM-CSF is highly similar to
orthologous sequences, it has several differences in helix A, a receptor-binding domain.
Phylogenetic reconstructions did not provide clear resolution of the relationship
between Seba’s short-tailed fruit bat and other placental mammals. Phylogenetic trees
from three cytokine genes (TNF, IL-23a, and GM-CSF) placed Seba’s short-tailed fruit
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bat in an unresolved position at or near the base of the tree. IL-10 provided the best
phylogenetic resolution among taxa, placing Seba’s short-tailed fruit bat in a clade
containing domestic dog and domestic cat. This placement corresponds to recent
mammalian phylogenetic analyses, which group bats, dogs, and cats into the
Superorder Laurasiatheria [206]. However, Superorder Laurasiatheria also contains
cattle, horse, and pig, which are dispersed throughout the IL-10 phylogenetic tree. The
general lack of phylogenetic resolution indicates that additional taxonomic sampling will
be required to accurately document the evolutionary divergence of these cytokine genes.
Parsimony is commonly used in phylogenetic analyses because it is relatively
simple and generates phylogenetic trees using as few steps as possible. This method
implies an evolutionary relationship and that the most simple explanation is likely the
best [198]. It should be noted that other methods of phylogenetic analysis such as
neighbor-joining or un-weighted pair group method with arithmetic mean (UPGMA),
could lead to the generation of phylogenetic trees with different cladistic groupings. This
is because each method uses different criteria for placing sequences into clades.
Additional phylogenetic analyses using different methods of tree construction could be
useful in resolving the evolutionary divergence of these cytokine genes.
Cloning and sequence analysis of additional cytokine genes and other immune
related transcription factors of Seba’s short-tailed fruit bat will allow the continued
assessment of immune responses. It is believed these primer sets could be used for
amplifying and cloning orthologous sequences from bats of many other species. In
addition, the little brown bat (Myotis lucifugus) genome has been sequenced (7x, Broad
Institute, Cambridge, MA), which should provide an important genomic resource for
research efforts regarding reservoir bat host responses to viral infections.
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Figure 1. Amino acid alignment of TNF sequences. Seba’s short-tailed fruit
bat cDNA was translated using the default translation table in MacVector DNA
analysis software. The human, chimp, rhesus monkey, dog, cat and mouse TNF
sequences were imported into MacVector from NCBI (accession numbers in
table 2) and aligned using the default parameters in the CLUSTAL algorithm.
Regions of sequence outlined in dark gray represent either consensus amino
acid identities or similarities and white areas indicate non-similar amino acids.
The consensus sequence is found at the bottom of the alignment. The bar that is
denoted TM above the alignment represents the region of TNF that is involved in
the transmembrane domain. Residues marked with asterisks represent
conserved residues that are involved in biological function of TNF.
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Figure 2. Amino acid alignment of IL-10. Seba’s short-tailed fruit bat IL-10 amino acid sequence was aligned with
other orthologous mammalian IL-10 sequences as described in Figure 1. Lettered bars (A, B, C, D, E) above the
alignment indicate helix regions and the four asterisks denote conserved cysteines that form intrachain disulfide
bonds.
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Figure 3. Amino acid alignment of IL-23a. Seba’s short-tailed fruit bat IL-23a
amino acid sequence was aligned with other IL-23a sequences as described in
figure 1. Lettered bars (A, B, C, D) above the sequences denote four helix
regions and asterisks indicate conserved cysteine residues.
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Figure 4. Amino acid alignment of GM-CSF. Seba’s short-tailed fruit bat GM-CSF amino acid sequence was aligned
with other mammalian GM-CSF sequences as described in figure 1. The region denoted with L indicates a 25 amino
acid signal peptide, and region A indicates a partially conserved helix A. A highly conserved β1 strand is marked with
a bar above the alignment. A highly conserved Helix B and an incomplete Helix C are
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Figure 5. Most parsimonious phylogenetic tree reconstructions based on cytokine gene amino acid
sequences. Genes are as follows: A, TNF; B, IL-10; C, IL-23a; D, GM-CSF. Bootstrap values greater than 50% are
shown above the branches.
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Tables
Table 1. Primer sequences used to clone partial cytokine cDNAs from Seba’s short-tailed fruit bat. Sequences listed
5’ to 3’.
Gene

Forward

Reverse

Size (bp)

TNF

GCGACGTAGAACTGGCAGAGG

CTGCGAAGTCTAGGTATTTGG

648

IL-10

CTCAGCACTGCTCTGTTGCC

454

IL-23a

1
2
1
2
3
4

1 GATGTCAAACTCAGTCATGG
2 GATGTCAAACTCATTCATGG
CTGCTCCGTGGGCAAAGACC
1 ATGGTCAAGGGGCCCTTGAG
2 ATGGTCAAGGCGCCCTTGAG

293

GM-CSF

AGCCAGATCTGAGAAGAAGG
AGCCAGATCTGAGAAGCAGG
CTGGAGGATGTGGCTGCAG
CTGGAGGATGTGGCTGAAG
CTGGAGGATGTGGCTTCAG
CTGGAGGATGTGGCTTAAG

311

Table 2. RACE primer sequences used to amplify 5’ cDNA regions of Seba’s short-tailed fruit bat cytokine genes.
Sequences listed 5’ to 3’.
Gene
Forward
Reverse
IL-10

TCGCCCTTCTCAGCACTGCTCTGTTGCC

GTTTGGGCAGGTTGGCTGGGAAGTCACTG

IL-23a

TGCCTGAAGGCAGCGGCCCCTCTTG

TCCACACGTCCATGGCTGGATGTGC

GM-CSF

CCTGCTTCTTCTGGGCACAGTGGCTTGC

GCGCCCTTGAGTATGGTGAGGTTGCCCC
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Table 3. Polypeptide accession numbers of sequences used from NCBI

Polypeptide

TNF

GM-CSF

IL-10

IL-23a

Human

NP_000585.2

AAU21240.1

CAG46825

AAH66267.1

Chimp

NP_001038976.1

XP_527005.2

XP_525040.1

XP_522436.1

Rhesus
monkey

NP_001040614.1

NP_001028121.1

ABI63892.1

NA

Dog

NP_001003244.4

NP_001003245.1

NP_001003077.1

XP_538231.2

Cat

NP_001009835.1

AAN11308.1

AAC64708.1

ABB01676.1

Mouse

NP_038721.1

NP_034099.2

NP_034678.1

NP_112542.1

Horse

NP_001075288.1

AAL41017.2

Q28374.1

ABZ91982.1

Cattle

DAA16338.1

P11052.1

NP_776513.1

ACC77208.1

Pig

NP_999187.1

NP_999283.1

NP_999206.1

NP_001123708.1

Platypus

NA

NA

NA

XP_001517448.1

Chicken

NP_989598.1

NP_001007079.1

NP_001004414.2

NA
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CHAPTER IV
EXPERIMENTAL INFECTION SUGGESTS JAMAICAN FRUIT
BATS (ARTIBEUS JAMAICENSIS) ARE NOT
RESERVOIRS OF TACARIBE VIRUS
Abstract
Tacaribe virus (TCRV) was first isolated from nine Artibeus sp. bats captured in
Trinidad in the early 1960s during a rabies virus surveillance program. Despite
significant effort, no evidence of infection of other mammals, mostly rodents, was found
that suggested other species harbored TCRV. For this reason, it was hypothesized that
Artibeus bats naturally hosted TCRV. This is in stark contrast to other arenaviruses with
known hosts in which all are rodents. Experimental infections of Jamaican fruit bats (A.
jamaicensis) with TCRV were performed to examine this hypothesis. It was predicted
that bats would become persistently infected without substantial pathology. Jamaican
fruit bats were infected with TCRV strain TRVL-11573 and it was found that low-dose
inoculations resulted in apathogenic infection and virus clearance, while high-dose
inoculations caused substantial morbidity and mortality as early as 10 days post
infection. In addition, transmission failed to occur in four experimental trials. Together,
these data suggest that Jamaican fruit bats are not a reservoir host species for Tacaribe
virus.
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Introduction
Bats (order Chiroptera) represent approximately one fifth of the 5,400 known
species of mammals [2]. In recent years, several bat species have been identified as
hosts for human and veterinary viruses and are likely reservoirs of other important
pathogens. Examples of viruses for which bats are reservoirs include rabies virus and
related lyssaviruses, Hendra and Nipah viruses, ebolaviruses and Marburg virus, and
SARS-like coronaviruses [9, 10, 14, 57, 59, 132]. Very little is known about virus-host
interactions in bats since bats have not been extensively studied and little is known
about their physiology, including immunology and host responses during infections.
Research suggests that some bats may become persistently infected with many viruses
without pathology [2, 114] and, because of a general lack of knowledge of bat biology it
is unknown how they may become persistently infected.
Tacaribe virus (TCRV) is an arenavirus, and like all other arenaviruses, it is
spherical, enveloped, and has a segmented single strand, ambisense RNA genome [38,
167]. While TCRV is not known to naturally cause human disease, at least two
instances of nonfatal laboratory infections have occurred. The Tacaribe virus complex
(New World) of arenaviruses includes Junín, Sabiá, Guanarito, Machupo and Chapare
viruses, which cause Argentine hemorrhagic fever (HF), Brazilian HF, Venezuelan HF,
Bolivian HF, and an as yet unnamed hemorrhagic fever, respectively [36, 38, 166, 207].
Previously, Tacaribe virus was isolated from Jamaican fruit bats and great fruiteating bats (A. lituratus) near Port of Spain, Trinidad during a rabies virus surveillance
program [33, 34]. Examination of more than 2,000 mammals, principally small rodents,
in Trinidad failed to provide serological evidence of infection and led to the suggestion
that Artibeus bats were reservoirs of TCRV [33]. This is unusual because all other
arenaviruses with known hosts are rodent-borne [71, 208]. When TCRV was isolated
from Jamaican fruit bats, it was observed that some bats appeared healthy while others
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exhibited symptoms of rabies and were mistaken as rabid bats [33]. Previous
experimental infections in rodents found that TCRV was lethal to newborn mice, causing
paralysis and necrosis in the central nervous system. In adult mice, limited replication
was observed and infection was avirulent [42, 166]. Experimental infection of Jamaican
fruit bats with TCRV were attempted when the virus was first isolated; however, bats
used in the experiment were wild-caught and not pre-bled prior to the experiment to
determine serostatus. Results from these infections were inconclusive and may have
been influenced by previous natural infections [33]. TCRV can cause persistent infection
of Vero E6 cells; however, it is unknown if it can cause persistent infections in Jamaican
fruit bats [77, 174].
Considering these ambiguous results that suggested Artibeus bats as reservoirs
of TCRV, and the fact that other arenaviruses have rodent reservoirs, this question was
reexamined under controlled laboratory conditions. Experimental infections of Jamaican
fruit bats with TCRV were conducted to examine pathology, virus tropism, viral shedding,
and whether the bats can become persistently infected. Bats inoculated with a highdose of TCRV exhibited clinical symptoms of disease resembling those of the South
American hemorrhagic fevers and either died or were euthanized for humane reasons.
Low-dose inoculations resulted in asymptomatic infections and virus clearance as
determined by PCR and virus isolation in cell culture. These findings suggest that
Jamaican fruit bats are not reservoir hosts of Tacaribe virus.
Materials And Methods
Bats
The University of Northern Colorado (UNC) bat colony has two species of
neotropical fruit bats, Seba’s short-tailed fruit bats and Jamaican fruit bats. These are
maintained together in a 36 m3 room that allows unrestrained free flight of all individuals.
The colony has been closed for 16 years and is rabies virus-free; PCR screening of
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rectal swab samples from 20 of these bats has failed to detect coronaviruses (K.
Holmes, pers. comm.) and serology samples for TCRV infections have been negative by
neutralization testing. The bats have access to roosting areas in the form of ceiling-hung
baskets and various cloth drapes and are maintained under a light-cycle of 12L:12D.
Ambient temperature is maintained between 20°C and 25°C and humidity between 50%
and 70% by a computer-controlled HVAC system. Bats are fed daily at midday with
grueled apples, monkey chow (Harlan Teklad, Denver, CO), molasses, nonfat dry milk,
cherry gelatin with raisins, and fresh bananas. In addition, a variety of other fruits,
including mango, papaya, cantaloupe, banana, grapes, and watermelon, are provided in
food trays and also arrayed on skewers throughout the room to stimulate foraging
behavior. For additional enrichment, artificial trees and vines are provided.
Jamaican fruit bats were obtained from the University of Northern Colorado bat
colony. Prior to infection, bats were transported to Colorado State University for
acclimation and infection under ABSL-3 conditions. All procedures were approved by the
University of Northern Colorado and Colorado State University Institutional Animal Care
and Use Committees and were in compliance with the USA Animal Welfare Act.
During each infection experiment, bats were placed three to a cage for a total of
four cages. Bats were fed a daily diet of fruit and water was made available in bowls
inside each cage. Individual bats were identified using numbered wing tags.
Experimental infections
Two sets of experimental infections were conducted over the course of two
years. Tacaribe virus strain TRVL-11573 propagated in Vero E6 cells was used for
these studies. The titer of virus stock was 107 virions per ml of BA1 media containing
5% FBS.
For the initial experiment, twelve male bats were each inoculated with 100 µl at
106 subcutaneously (SC) on the abdomen, and 25 µl at 105 intranasally (IN). Bats were
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monitored over the course of 18 days for development of pathological symptoms. As
part of the protocol, some bats were routinely euthanized to examine disease
progression. Two bats each were euthanized on day 4 PI, and day 8 PI. The remaining
eight bats were euthanized as they began to show pathological symptoms of disease. In
this initial experiment, one bat that was not housed with the twelve infected bats was
included as a negative control.
The second experiment included three male and nine female Jamaican fruit bats
that were randomly divided into four experimental groups receiving different doses and
routes of virus inoculation. Group one consisted of two bats that received 106 virus IN
and one bat that received PBS IN. Group two consisted of two bats that received 104
virus IN, and one bat that received PBS IN. Group three consisted of two bats that
received 106 virus SC in the abdomen and one bat that received PBS SC in the
abdomen. The fourth group consisted of two bats that received 104 virus SC in the
abdomen, and one bat that received PBS SC in the abdomen. Bats were monitored for
development of pathological symptoms over the course of 45 days. Any moribund bats
were immediately euthanized.
In both experiments, intranasal inoculations were performed using a
micropipettor and a sterile tip to administer the correct dose. Subcutaneous injections
were performed using a sterile hypodermic syringe and needle. Inoculations were
performed in a biosafety cabinet without anesthesia.
Weight records
Bat weights were recorded only on day zero during the initial experiment and
every two days during the second experiment. During the second experiment, weights
were recorded to examine the effect of viral infection on feeding behavior and weight
gain or loss. Bats were carefully rolled up in a piece of cloth and placed on a balance to
obtain weight in grams.
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Swab collection
Oral and rectal swabs were routinely collected from each bat every two days to
examine virus shedding. Oral and rectal swabs were collected from each bat using
sterile cotton-tipped swabs. All oral and rectal swabs were collected and expressed in
500 µl of BA1 media containing 5% FBS and were frozen at -80oC until processed.
Serum sample collection
Serum samples were routinely collected from each bat every two days. Bats
were bled from the wing using a sterile 22-gauge needle and capillary collection tubes.
Approximately 100 µl of blood was collected from each bat on collection days and placed
into 200 µl of BA1 media containing 5% FBS. Following euthanasia final serum samples
were collected by cardiac puncture. Serum samples were used in virus isolation and
neutralizing antibody tests.
Organ sample collection
All bats were euthanized by an intracardiac injection of sodium pentobarbital.
Necropsies were performed directly following euthanasia. Organ samples were
collected for examination using conventional PCR, and virus isolation on Vero E6 cells
followed by immunofluorescent antibody tests. All organ samples were frozen at -80o C
until processed. In the first experiment, testes, kidney, heart, lung, liver, spleen, large
intestine, small intestine, and brain samples were collected. In the second experiment,
organ sampling was the same except for the collection of the uterus from female bats,
and the addition of collecting salivary glands.
Ribonucleic acid extraction
TCRV viral RNA was extracted from BA1 media containing 5% FBS that had
been used to collect oral and rectal swabs using QIAamp (Qiagen, Valencia, CA) Viral
RNA mini kits according to the manufacturer’s instructions. All RNA samples were
frozen at -80o C until used for reverse transcription.
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RNA was extracted from bat organ samples collected in RNAlater stabilization
reagent (Qiagen, Valencia, CA). Organ samples were placed in 1.5 mL screw cap tubes
and approximately twelve 2.3 mm zirconia/silica beads (BioSpec Products Inc.,
Bartlesville, OK) were added to each tube. A mini bead-beater (BioSpec Products Inc.,
Bartlesville, OK) was used to homogenize the organ samples. RNA extraction was
performed using QiaShredder columns (Qiagen, Valencia, CA), and RNeasy mini kits
(Qiagen, Valencia, CA) according to manufacturer’s instructions. All RNA samples were
immediately frozen at -80oC until used for reverse transcription.
Reverse transcription and Polymerase
chain reaction
RNA from oral swabs, rectal swabs, and organ samples was reverse-transcribed
using qScript TM cDNA synthesis kits (Quanta Biosciences, Gaithersburg, MD) according
to manufacturer’s instructions. PCR was performed using Promega (Madison, WI) 2X
PCR master mix kit and appropriate TCRV primers (Table 8, see page 91).
Amplification was performed using 35 cycles of 94°C for 30 seconds, annealing at 56°C
for 30 seconds, and extension at 72°C for 1 minute. After 35 cycles, the reactions were
held at 72°C for 10 minutes and finally held a 4°C until used. Amplified PCR samples
were then resolved and visualized using a 1% agarose gel.
Cloning and sequence analysis
Several PCR products from organ samples were cloned and sequenced to verify
amplification of TCRV. PCR products were cloned into TOPO-TA (Invitrogen, Carlsbad,
CA) cloning vector according to the manufacturer’s directions. Clones were then used to
transform One Shot Chemically competent E. coli cells (Invitrogen, Carlsbad, CA), which
were subsequently plated and grown on LB/ampicillin plates. Bacterial colony screening
was performed using Promega (Madison, WI) 2X PCR master mix kit and TCRV primers
to verify plasmid insert. Colonies with the TCRV insert were then incubated at 37°C
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overnight in 4 mL of LB broth with 50 µg/ml ampicillin. Plasmids were then purified using
a QIAprep spin Miniprep kit (Qiagen, Valencia, CA) according to manufacturer’s
directions. Plasmid recovery was confirmed using a 1% agarose gel. Sequencing
reactions were performed using T7 and T3 primers with Big Dye Terminator (Applied
Biosystems, Foster City, CA). Sequencing reactions were sent to CSU Macromolecular
Services for sequencing. Sequencing files were edited using Sequencher (GeneCodes,
Ann Arbor, MI) and BLAST (basic local alignment search tool) was used for gene
identification.
Virus isolation
Organs that had previously been frozen at -80 C° were thawed in 500 µL of BA1
media containing 5% FBS. Approximately twelve 2.3 mm zirconia/silica beads (BioSpec
Products Inc., Bartlesville, OK) were added to each tube and tissues were homogenized
using a mini bead-beater (BioSpec Products Inc., Bartlesville, OK). Tubes were
centrifuged at 13,000 rpm for 5 minutes to separate virus-containing supernatant from
remaining solid tissue. Supernatants were then diluted into 96-well tissue culture plates
in a log 10 dilution series beginning with neat supernatant and leaving the last row blank
as a negative control. Supernatants were then added to a corresponding plate
containing confluent Vero E6 cells. Cells were incubated with supernatants for 24 hours,
at which point fresh media was added. Cells were kept at 37 °C, 5% CO2 for 7 days.
Cells were evaluated for presence of virus using immunofluorescent antibody staining.
Media was removed and cells were fixed by incubating with acetone for 120 minutes.
They were then incubated with mouse anti-TCRV ascites fluid diluted 1:200 in PBS for
30 minutes at 37° C. Cells were washed with 1X PBS and incubated with a 1:1600
dilution of DyLight goat anti-mouse IgG (Jackson Immunoresearch Cat.# 115-485-003),
and incubated 30 minutes at 37° C. Cells were again washed and stored in 1X PBS
protected from light until evaluation with a fluorescent microscope. The same protocol
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for virus isolation was used on terminal serum samples from each experiment. Wells
were evaluated as positive for virus isolation if greater than 25% of Vero E6 cells in each
well were fluorescing.
Neutralizing antibody tests
Terminal serum samples from each bat were screened for anti-TCRV neutralizing
antibody by neutralizing antibody tests and immunofluorescence. Fifty microliters of
each serum sample was diluted with 75 µl of BA1 cell culture media and heat inactivated
in a water bath for ten minutes. Heat-inactivated serum samples were diluted 1:2 with
BA1 cell culture medium and placed in the first well of a 96-well tissue culture plate. Log
2 dilution series were made for each sample. A dilution series was performed with
mouse anti-TCRV ascites fluid in BA1 cell culture medium, without the addition of serum
to serve as an anti-TCRV positive control. A negative control sample was included by
performing a dilution series with TCRV in BA1 cell culture medium, without the addition
of serum. After all dilutions were made, 50 µl of TCRV (diluted 1:1 with BA1 cell culture
media) was added to each well. Plates were then incubated at 37° C for 60 minutes.
Fifty microliters of Vero E6 cells were then added to each well at a concentration of
400,000 cells per milliliter. Plates were kept at 37 °C, 5% CO2 for 7 days. Cells were
then screened for presence of TCRV infection using immunofluorescence, as was
previously described for organ sample virus isolations.

Histopathology
Tissues were removed from bats at necropsy and collected in buffered formalin.
Specimens were prepared and sectioned by Colorado Histprep, Inc. for evaluation by a
veterinary pathologist (DG).
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Results
Experimental infections
In the first experiment, twelve bats were inoculated with 106 TCID50 (100 µl)
subcutaneously (SC) and 2.5x105 TCID50 (25 µl) intranasally (IN) to determine TCRV
susceptibility. During the initial experiment, it was planned to euthanize two bats on days
4, 8, 12, 16, and 28 post-infection (PI). Two bats were euthanized on day 4 and day 8
PI, but on day 10, bats began to show pathological symptoms of disease and some
exhibited tremors and were unable to fly. One bat was found dead on day 10 PI and
another was moribund on day 11 PI and was euthanized (Figure 6, see page 84). One
bat was found dead on day 13 PI and another on day 16 PI. Two more bats became
moribund on day 17 PI and were immediately euthanized. On day 18 PI, a bat was
found dead and the last two bats were moribund and were euthanized. Symptoms of
moribund bats included being poorly responsive to mechanical stimuli, abnormal wing,
ear and head tremors, inability to coordinate movement, and inability to fly when
released.
In the second experiment, two bats each were inoculated with high-dose IN (106
TCID50), low-dose IN (104 TCID50), high-dose SC (106 TCID50) or low-dose SC (104
TCID50) and were euthanized for humane reasons only if they showed pathological signs
of disease. Included in each of these four cages was one uninfected bat to assess
transmission. On day 21 PI, a bat that had received a 106 IN inoculation became
moribund and was euthanized, and on day 23 PI, a bat that had received a 106 SC
inoculation became moribund and was euthanized. On day 25 PI, a second bat from the
106 IN group became moribund and was euthanized. The remaining nine bats did not
exhibit pathological symptoms during the 45 day experiment. The three bats that
became moribund experienced the same symptoms as described in the initial
experiment.
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Bat weights
Bat weights were only recorded on day 0 in the initial experiment. In the
second experiment, bat weights were recorded every two days as well as days that bats
became moribund or were found dead. Bat weights appeared to fluctuate somewhat
throughout the experiment with a notable decrease in weight as bats became moribund
(Figure 7, see page 85).
Oral swab polymerase
chain reaction
In the initial experiment, all oral swabs collected on days 0, 2 and 4 PI, were
negative for virus by PCR (Table 4, see page 87). On day 6 PI, oral swabs from several
bats were positive for virus and continued to show positive PCR results throughout the
duration of the experiment.
In the second experiment, oral swabs collected on day 0 were all negative for
viral RNA by PCR (Table 5, see page 88). On day 2 PI, the oral swab collected for one
bat was positive. All of the day 4 PI oral swabs were negative, but by day 6 PI, oral
swabs for five of the bats were positive for virus. Most of the bats continued to show
positive oral swab PCR results throughout the experiment.
Rectal swab polymerase
chain reaction
In the initial experiment, rectal swabs collected on days 0, 2, and 4 PI were
negative for virus by PCR. By day 6 PI, and continuing through the entire experiment,
many bats show rectal swabs that are positive for virus (Table 4, see page 87).
In the second experiment, rectal swabs collected on days 0, 2, 4, and 6 PI were
negative for virus. From day 8 PI, continuing through day 45 PI, rectal swabs for many
of the bats show positive results for virus by PCR (Table 5, see page 88).
Organ sample polymerase
chain reaction
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Organ samples collected during the initial experiment show that 11 of the 12 bats
were positive for virus by PCR in several organ samples. One bat was not PCR positive
for virus in any organ sample, and two other bats only showed positives in one organ
sample each. The remaining nine bats were PCR positive for virus in multiple organs
(Table 6, see page 89).
Organ samples collected during the second experiment show that only three of
the twelve bats were positive for virus by PCR in various organ samples. One bat was
positive in the brain only, while the other two bats were positive for virus by PCR in
multiple organ samples (Table 7, see page 90).
Virus isolation
Virus isolation was attempted from organ homogenates from the initial
experiment using Vero E6 cells followed by IFA (Table 6, see page 89) and were
congruent with PCR results. Virus isolation from the second experiment also supported
the findings from the organ PCR results with only two bats positive for virus in the organs
(Table 7, see page 90). The same two bats were also positive for virus in the organ
samples by PCR. Virus was not isolated from terminal serum samples in either of the
infection experiments.
Neutralizing antibody test
Neutralizing antibody tests on terminal serum samples from the first experiment,
in which bats died or were euthanized between 10 and 18 days PI, were negative. Only
three bats from the second experiment had neutralizing antibody. All three of these bats
were in subcutaneous inoculation groups and were negative for virus by PCR (Table 7,
see page 90).
Histopathology
Tissues from the initial infection experiment were submitted for pathological
examination. Eleven bats had neutrophilic interstitial pneumonia that ranged from mild to
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moderate in severity, and with multifocal to diffuse distribution, while bat 738 exhibited
no remarkable lesions. Six of the bats (bats 718, 747, 714, 720, 729, 738) exhibited
myocardial lesions without inflammation, fibrosis or degenerate myofiber loss. Three
bats (747, 714, 748) exhibited mild to moderate multifocal adrenocortical necrosis, and
mild to moderate multifocal hepatocellular necrosis and vacuolar hepatocellular
degeneration was observed in several bats (645, 647, 705, 747, 712). Most bats
exhibited mild to moderate neutrophilic enteritis with crypt necrosis and epithelial
degeneration.
Spleens from bats were grouped in two categories based upon histopathology:
acute neutrophilic splenitis and white pulp hyperplasia/plasmacytic and histiocytic
splenitis. Neutrophilic infiltration of the white pulp with fibrin tagging of the capsule
occurred in many bats (645, 647, 705,747, 714, 712), which may be related to changes
in the peritoneum; however, no conspicuous peritonitis was observed. The white pulp
changes appear to be the result of proliferating lymphocytes instead of inflammation as
plasma cells were often abundant.
Two bats (712 and 729) had lymphocytic leptomeningitis and mild to moderate
multifocal gliosis in the brainstem and prosencephalon. Bat 712 also had mild
neutrophilic encephalitis of the prosencephalon (Figure 8, see page 87).
Both of these bats, as well as bat 738, were PCR positive for viral RNA and
exhibited tremors prior to euthanasia. Bat 714 was also PCR positive, but had died on
day 11 PI and no tremors had been observed on day 10 PI. No remarkable lesions were
observed in kidneys, ureters, bladder, testicles, thymus, esophagus, salivary gland,
pancreas or stomach samples.
Discussion
Arenaviruses, for which the reservoirs are known, are rodent-borne. The one
exception has been Tacaribe virus, which was thought to be hosted by Artibeus bats

79
based upon natural infections and virus isolation from bats, and a lack of evidence of a
rodent host. This possibility has been addressed by infecting Jamaican fruit bats with
TCRV and the results suggest that Jamaican fruit bats are not a likely reservoir of TCRV.
Conducting experimental infections with bat models are challenging because of
the unique attributes of bats. The establishment of breeding colonies usually requires
free-flight enclosures, appropriate foods, enrichment, including those that stimulate
foraging behavior, and appropriate climate control to facilitate the highly social
development of the colony. In addition, reproductive female bats typically produce one
to three offspring per year and invest heavily in maternal care [175]. For Artibeus bats,
reproductive females typically produce two pups per year in the wild, a number
consistent with females in the UNC colony. This presents difficulty in conducting
experiments with large sample sizes and, thus, can be a limiting factor in research with
bats. Despite these limitations, efforts to infect Jamaican fruit bats with Tacaribe virus
were successful.
Different doses and routes of TCRV inoculation were examined in the first and
second infection experiments. Initial experiments were performed with coinoculation of
high dose and two routes to determine if Jamaican fruit bats could be infected with
TCRV strain TRVL-11573. TCRV was isolated in the early 1960s from the brain of a
great fruit-eating bats (A. lituratus) and has an unknown passage history [33]. Initially, it
was propagated in newborn mice and at some point the virus was subsequently
propagated in Vero E6 cells.
It was found that this method of inoculation resulted in infection of Jamaican fruit
bats with pathological symptoms and deaths. With the exception of the first four bats that
were euthanized on schedule (two each on days 4 and 8), all remaining bats either died
or became moribund and were euthanized for humane reasons. None of the bats
survived past day 18 of the experiment.
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In the second experiment, dose and route were partitioned between four groups
(104 virus SC or IN, or 106 virus SC or IN) to determine the effect of dose and route.
Three of the eight inoculated bats became moribund during the experiment and each
was from high-dose groups.
In both experiments symptoms of moribund bats included poor response to
mechanical stimuli, abnormal wing, ear and head tremors, inability to coordinate
movement, weight loss and inability to fly when released. These symptoms are
consistent with previous findings from Downs et al. [33].
Results from oral and rectal swabs suggest that some infected bats shed virus
from excrement, which typically occurs in rodent reservoirs of other arenaviruses [71,
73]. In the first experiment, not all bats shed virus; however the two that had negative
oral or rectal swabs, were euthanized on day 4 PI and were not likely to be shedding
virus that early in the infection. The remaining 10 bats all showed positive oral or rectal
swabs at some point during the experiment (Table 4, see page 87). Many bats
appeared to be shedding virus either orally or rectally on specific days during the
experiment, and not on other days. For example, in Table 4 (see page 87), bat number
720 appeared to be shedding virus rectally on days 6, 10, 12, and 16 PI, but not on day
8 PI. It is likely they were shedding virus, although it may not have been enough to be
detected by PCR. This pattern was observed for many of the oral and rectal swabs
collected for each of the bats in both experiments (Tables 4 and 5, see pages 87 and
88). During the first experiment, all remaining bats appeared to be shedding virus by
day 10 PI. A similar pattern was observed in the second experiment, as all bats
appeared to be shedding virus either orally or rectally by day 18 PI. The longer period of
time between inoculation and virus shedding in the second experiment could have been
due to bats receiving lower doses of virus, or the single route of inoculation. While three
bats became moribund and were euthanized during the second experiment, the other
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nine remained healthy and appeared to still be shedding virus (by PCR) on day 45 PI
without pathological symptoms. However, it is uncertain if infectious virus was still
present in the intestines of the surviving bats.
Organ sample PCR results from the first experiment showed all but one bat had
viral RNA in various organs. The one negative bat was euthanized on day 4 likely before
virus could be detected in the organs. There appeared to be no discernable pattern of
virus distribution in the organs except for first detection in the spleen, and last in the
heart and brain (Tables 6 and 7, see pages 89 and 90). It is possible that once virus
reaches the brain death ensues rapidly. However, not all bats that became moribund or
died in the first experiment had detectable virus in the brain. In the second experiment,
only three bats were positive for virus in the organs, and there was no pattern of virus
progression through the organs over time. For each experiment, virus isolation results
were congruent with PCR results (Tables 6 and 7, see pages 89 and 90).
Neutralizing antibodies were found in the terminal serum samples of three bats
from second experiment. These results suggest the bats mounted an immune response
that cleared the virus.
Virus transmission was examined during the second experiment by including one
uninfected bat in each experimental group. All uninfected bats were negative for virus
by PCR on collected organ samples; however, all uninfected bats showed positive oral
or rectal swabs for virus by PCR at some point in the experiment. None of these bats
seroconverted nor had virus detected in organs by PCR or virus isolation. With no virus
being detected in the organs of uninfected bats by PCR or virus isolation, it is likely that
oral and rectal swab PCR results represent detection of contaminating virus RNA from
the infected bats. This is suggested because these bats huddle closely together and
typically engage in grooming activities of one another. Grooming and close contact
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could lead to viral RNA detection in uninfected bat swabs. Thus, this experiment
provides no support for transmission.
Histopathology from the first experiment revealed multiple organ involvement in
TCRV disease. Pneumonia was noted in all but one bat and the livers and spleens had
pathological changes as well. Three bats exhibited brain lesions and each exhibited
tremors and were PCR positive for TCRV RNA, while a fourth brain PCR positive bat
died early in the experiment on day 11 also exhibited tremors but had no remarkable
brain lesions by histopathology. Tremors are also a feature of some cases of South
American hemorrhagic fevers [209], suggesting bats as a potential model for human
disease.
These experimental infections show that Jamaican fruit bats are susceptible to
TCRV and that a high dose results in significant and fatal disease. Low-dose infections
appeared to result in no disease, seroconversion in some and no detection of virus in
organs. It was not possible to demonstrate transmission between bats despite the close
contact of infected and uninfected bats for 45 days. Together, these data are not
supportive of the hypothesis that Jamaican fruit bats are reservoirs of TCRV.
The distributional range of Jamaican fruit bats is throughout tropical Central and
South America, the West Indies, including the Greater and Lesser Antilles, Trinidad and
Tobago, the Yucatan and the Florida Keys [175]. Jamaican fruit bats are capable of
flying long distances to forage [49, 175, 210, 211] and genetic studies indicate
bidirectional movement of Jamaican fruit bats between the Antilles islands and mainland
Mexico and South American countries [211, 212]. Trinidad, where TCRV TRVL-11573
was isolated, is 10 km from Venezuela and within the flight range of Artibeus bats [211].
It is possible that Jamaican fruit bats from which TCRV was first isolated may have been
infected with TCRV in Venezuela or elsewhere and introduced the virus to the Antillean
islands before experiencing pathological symptoms (which took 11 days to occur in the
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work presented here). This could account for the lack of serological evidence in other
mammals surveyed in Trinidad as reported by Downs et al [33].
The 19 isolates reported by Downs et al. (from 6 A. jamaicensis and 5 from A.
lituratus) have apparently been lost, with the exception of TRVL-11573; although they
were indistinguishable by complement fixation testing [33]. It is also possible that
passage of TCRV TRVL-11573 in mice and cell culture has led to the selection of
mutations that have altered the virus’ infectious characteristics that are reported here,
such that wild-type viruses may indeed be hosted by Artibeus bats but with different
infectious outcomes. It is also possible that the routes of infections used (SC or IN;
uninfected cage mates) do not replicate natural transmission, which could alter infectious
outcome. Without having any of the original 19 isolates it is impossible to determine,
thus additional fieldwork would be required in an attempt to reisolate virus. Finally, it is
important to note that TRVL-11573 was isolated from a greater fruit-eating bat and thus
its characteristics may differ in Jamaican fruit bats.
With other arenavirus infections, such as Guanarito virus infection of its natural
reservoir, the cane mouse (Zygodontomys brevicauda) [71], and hantavirus infections of
their hosts [68] interactions indicate the viruses cause persistent infections but without
pathology, which was not observed in experimental bat infections. Thus, the weight of
evidence suggests that Jamaican fruit bats are not reservoirs of TCRV.
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Figure 6. Tacaribe virus is lethal to Jamaican fruit bats. Two bats were euthanized on days 4 and 8 PI and were
asymptomatic. However, on day 10 one bat was found dead and during the next 8 days remaining bats died or were
euthanized for humane reasons.
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Figure 7. Weight changes after inoculation with Tacaribe virus. Weight loss was recorded for the 106 SC (A), 106 IN (B),
104 SC (C) and 104 IN (D) groups. Bats that survived had minimal weight fluctuations during the 45 day experiment. However,
bats that became moribund (674, 676 and 677) each had weight decline prior to euthanasia. Each number represents an
individual bat.
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Figure 8. Histology of tissues from TCRV-infected bats in initial
experiment. Bat 712 with encephalitis and multifocal gliosis (A). Bat 712 with
lymphocytic meningitis (B). Bat 712 with interstitial pneumonia (C). Bat 718 with
multifocal myocardial degeneration (D). Bat 718 with focal hepatic necrosis (E).
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Table 4. Oral and rectal swab PCR results from the first experiment. An X
indicates a PCR positive swab. Shaded in boxes indicate days that swabs were
not collected from bats that died or were euthanized.

Bat

DPI
Euth/Died

DPI

0

2

4

6

8

X

X

X

X

10

12

16

Swabs
645

4

Oral
Rectal

647

4

Oral
Rectal

747

8

Oral
Rectal

705

8

Oral
Rectal

714

11

Oral
Rectal

703

12

X

Oral
Rectal

718

13

Oral

X
X

Rectal
748

16

X

Oral

17

X

17
18
18

X
X

X

X

Oral
Rectal

738

X

Oral
Rectal

729

X

Oral
Rectal

720

X
X

Rectal
712

X

X
X

X

X

Oral

X

Rectal

X

X
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Table 5. Oral and rectal swab PCR results from the second experiment. An X indicates a PCR positive swab. Shaded in
boxes indicate days that swabs were not collected from bats that died or were euthanized.

Bat
691

Dose/Route

DPI

UI 104 IN

45

680

104 IN

45

675

104 IN

45

688

UI 106 IN

45

677

106 IN

25

676

6

10 IN

21

681

UI 104 SC

45

679

104 SC

45

673

104 SC

45

689

UI 106 SC

45

678
674

6

10 SC
6

10 SC

45
23

Days:
Swabs
Oral
Rectal
Oral
Rectal
Oral
Rectal
Oral
Rectal
Oral
Rectal
Oral
Rectal
Oral
Rectal
Oral
Rectal
Oral
Rectal
Oral
Rectal
Oral
Rectal
Oral
Rectal

0

2

4

6

8

10

12

14

18

23

X

X

X
X

X

X
X

X
X

30

34

X
X

X
X
X

X

X

X

X
X

27

X
X
X
X

X

X
X
X
X
X

X
X
X

X
X

X
X
X
X

X
X

X
X
X
X

X
X

X
X
X
X
X

X

X

X

X

X

45

X
X

X
X
X

41

X

X

X
X
X
X

X
X
X

X
X
X
X
X
X
X

X
X
X
X
X
X

X
X

X
X

X

X

88

89

Table 6. Organ sample PCR and virus isolation results from the first experiment. An X indicates PCR positive organ
samples. An O indicates PCR positive as well as virus isolation positive organ samples. Bat numbers marked with an
asterisk indicate bats that experienced neurologic symptoms. DPI Euth/Died numbers shown in bold indicate bats that were
found dead.

Bat

645

647

747

705

703

714*

718

748

712*

720*

729*

738

4

4

8

8

10

11

13

16

17

17

18

18

DPI Euth/Died
Organ
Testes
Kidney

X

X

Heart

X

X

X

X

X

X

X

X

X

X

X

O

O

X

X

X

X

O

X

X

X

X

Lung

X

X

Liver

X

X

O

O

X

X

X

X

X

X

X

X

X

X

X

O

O

X

X

X

X

X

O

O

O

X

O

X

Spleen
Lg. Intestine
Sm. Intestine
Brain

X

X

X

X

X
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Table 7. Organ sample PCR, virus isolation, and neutralizing antibody test results from the second experiment. An X
indicates PCR positive organ samples. An O indicates PCR positive as well as virus isolation positive organ samples. Bat
numbers marked with an asterisk indicate bats that experienced neurologic symptoms. Boxes marked with an asterisk *
denote bats positive for neutralizing antibody.

Bat

Dose/Route
DPI Euth/Died

691

680

657

4

4

UI 104
IN

10 IN

45

45

688

677*

676*

6

6

10 IN

UI 106
IN

10 IN

10 IN

45

45

25

21

681
UI
104
SC
45

679

673

104
SC

104
SC

45

45

689
UI
106
SC
45

678

674*

106
SC

106
SC

45

23

Organ
Reproductive
Kidney

X

Heart
Lung

X

X

Spleen

O

X

Lg. Intestine

X

Sm. Intestine

O

Brain

X

Liver

X
X

O

Salivary
Neut. Ab

*

*

*
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Table 8. TCRV primer sequences listed 5’ to 3’.
Forward TCRV PCR primer
AATTTGCGATCGAGAGCCTA

Reverse TCRV PCR primer
AGCTCATCCCAAACCATGAG

Size (bp)
316
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CHAPTER V
WORK TOWARD THE DEVELOPMENT OF A RAPID FIELD
IMMUNOASSAY FOR DETECTING ANTIBODY
TO TACARIBE VIRUS IN MAMMALS
Abstract
Work to develop a rapid field immunoassay that could be used for detection of
antibody to Tacaribe virus in mammals has been initiated. Tacaribe virus is an
arenavirus that was isolated from Jamaican fruit bats in Port of Spain Trinidad during a
rabies virus surveillance program in the early 1960s. The natural reservoir of TCRV is
uncertain, but due to the original isolation from bats, it was hypothesized that species of
Artibeus bats were the natural reservoir. If it were found that Tacaribe virus is hosted by
Artibeus bats it would be unusual because arenaviruses, for which the hosts are known,
are rodent-borne viruses. By way of experimental infections, it has recently been
identified that Jamaican fruit bats are not likely the reservoir of Tacaribe virus. These
findings reveal that the reservoir host to this arenavirus is still unknown. Development of
a rapid field immunoassay could be advantageous in discovering the natural reservoir of
Tacaribe virus by allowing the rapid screening of many mammalian species in the field.
A project to develop a rapid immunoassay is proposed by cloning and expressing a large
fragment of the Tacaribe virus nucleocapsid for use as an antigen in an immunoassay
using protein A/G-HRP conjugate.
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Introduction
Arenaviruses belong to the family Arenaviridae and the genus Arenavirus. They
are enveloped and have a single-strand, ambisense RNA genomes [167]. Arenaviruses
have two gene segments, the large (L) segment and the small (s) segment. The large
gene segment encodes an RNA-dependent RNA polymerase and a zinc binding protein
called RING finger protein Z. The small segment encodes the nucleocapsid protein and
a glycoprotein precursor. The structure of the arenavirus nucleocapsid is coiled and
circular in arrangement [168, 169, 213].
Arenaviruses are assigned to two categories; the Lassa virus complex (Old
World), and the Tacaribe virus complex (New World). The Lassa virus complex includes
Lassa virus, found in Africa, which is the etiologic agent of Lassa fever in humans,
Lymphocytic Choriomeningitis virus, which can cause aseptic meningitis in humans, and
Lujo virus, which causes hemorrhagic fever in humans [35, 37, 75, 84, 170]. The
Tacaribe virus complex includes Junín, Machupo, Sabia, Guanarito, and Chapare
viruses, which cause Argentine hemorrhagic fever (HF), Bolivian HF, Brazilian HF,
Venezuelan HF, and an as yet unnamed hemorrhagic fever respectively [35-38].
Arenaviruses, for which the hosts are known, are rodent-borne viruses. Many
arenaviruses can establish persistent infections in the rodent hosts without pathology
[40, 71, 172]. Phylogenetic studies have found that a tight coevolutionary relationship
between arenaviruses and their rodent hosts may exist, which could account for the
ability of the viruses to establish persistent infections without causing pathology [38, 67,
214].
Tacaribe virus (TCRV) is included in the Tacaribe virus complex, but it is not
known to cause natural human infection and does not have a known rodent reservoir.
TCRV was isolated from two species of Artibeus bats (A. jamaicensis and A. lituratus),
during a rabies surveillance program in Port of Spain Trinidad in the early 1960s [33].
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The isolation of TCRV from species of bats and the inability to identify TCRV in any
other species has led researchers to hypothesize that Artibeus bats are the natural
reservoir [33].
Experimental infections of Jamaican fruit bats with TCRV were performed to
examine the virus-host interactions. It was hypothesized bats would become
persistently infected with TCRV without developing pathology if they were reservoirs.
Failure to develop persistent infections, and the development of pathogenic symptoms
indicated that Jamaican fruit bats are not the reservoir of Tacaribe virus (Unpublished
results- Chapter IV). These findings reveal that the natural reservoir of TCRV remains
unknown. Serologic surveys of mammalian species in regions where Artibeus bats are
distributed are necessary to identify the natural reservoir. The aim of the study
presented here is to develop a rapid immunoassay for the detection of TCRV-specific
antibody.
Immunoassays, such as sandwich ELISAs have been developed for the
detection of Tacaribe virus and other arenavirus antigens, but these are not useful for
the rapid detection of virus-specific antibody in the field [179-181]. Sandwich ELISAs
can be used to detect current viral infections since they are designed to bind viral
antigen, but they are not useful for detecting antibody that has been produced in
response to a current or past infection. Indirect ELISAs are used to detect virus-specific
antibody in serum samples of mammals. Many of these immunoassays include the use
of whole virus as the antigen and species-specific secondary detection antibodies [110,
215].
Due to these requirements, many immunoassays may require 3 to 5 hours to
complete, and thus are not conducive to rapid screening projects in the field. There is
currently no indirect ELISA that may be used for the rapid detection of TCRV-specific
antibody in the field. A rapid field immunoassay was recently developed for screening
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populations of deer mice for SNV-specific antibody [16, 182, 216]. Development of a
rapid indirect immunoassay would be advantageous for the detection of TCRV-specific
antibodies in serum samples of bats captured in the field. Development of such an
assay has required the identification of immunodominant epitopes in arenaviruses, and
the production of an antigen that would be bound by TCRV-specific antibodies.
Studies using monoclonal antibodies (Mabs) have identified that arenaviruses
have several different antigenic sites. There are 4 antigenic sites on the nucleoprotein, 2
on glycoprotein 1 and 6 on glycoprotein 2 [217, 218]. Another study used sequencing
technology to examine antigenic characteristics of different types of arenaviruses. It was
found that several shared amino acids (NP 118-126) within the nucleoprotein of
arenaviruses make up the immunodominate cytotoxic T-lymphocyte (CTL) epitope in
mice. The authors used amino acid alterations in the area that encodes this epitope to
confirm that it is involved in binding CTLs and majorhistocompatability complex
molecules (MHC) [219]. It is likely that an immunodominant epitope specific for binding
TCRV-specific antibody can also be found on the nucleocapsid of TCRV. For this
reason, it has been an aim of this project to clone and express a large fragment of the
TCRV nucleocapsid.
Here, work that has been performed to develop a rapid field immunoassay to
detect Tacaribe virus-specific antibody is described. A protocol that had previously been
described for the development of a rapid protein-A/G horseradish peroxidase enzymelinked immunosorbent assay (PAGEIA) that detects antibody to SNV was followed [16,
110].
Materials And Methods
RNA extraction
TCRV viral RNA was extracted from supernatant of Vero E6 cells that had been
used to propagate Tacaribe virus strain TRVL-11573 using QIAamp (Qiagen, Valencia,
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CA) Viral RNA mini kits according to the manufacturer’s instructions. RNA samples
were immediately used in reverse transcription PCR and were then frozen at -80o C.
Reverse transcription and PCR
Reverse transcription (RT) and gene amplification were both performed using
TCRV specific primers (Table 9, see page 102) and a SuperScript III One-Step RT-PCR
System with Platinum Taq DNA Polymerase (Invitrogen, Carlsbad, CA). The reverse
primer sequence used for this amplification was a primer that had been designed in
previous studies [38]. cDNA synthesis and PCR amplification were performed using 1
cycle of 55°C for 30 minutes, 1 cycle of 94°C for 2 minutes, 40 cycles of 94°C for 30
seconds, 56°C for 30 seconds, 72°C for 2 minutes. After 40 cycles, reactions were held
at 68°C for 5 minutes followed by a hold at 4°C until used. PCR cycle parameters
detailed in the SuperScript III One-Step RT-PCR system were used. PCR products
were resolved and visualized using a 1% agarose gel.
Cloning and sequence analysis
PCR products were cloned into TOPO-TA (Invitrogen, Carlsbad, CA) cloning
vector according to the manufacturer’s directions. Clones were then used to transform
One Shot Chemically competent E. coli cells (Invitrogen, Carlsbad, CA) that were
subsequently plated and grown on LB/ampicillin plates. Bacterial colony screening was
performed using a Promega (Madison, WI) 2X PCR master mix kit and TCRV primers to
verify plasmid insert. Amplification was performed using 35 cycles of 94°C for 30
seconds, annealing at 56°C for 30 seconds, and extension at 72°C for 2 minutes. After
35 cycles, the reactions were held at 72°C for 10 minutes and finally held a 4°C until
used. Amplified PCR samples were then resolved and visualized using a 1% agarose
gel. Colonies with the TCRV insert were then incubated at 37°C overnight in 4 mL of LB
broth with 50 µg/ml ampicillin. Plasmids were then purified using a QIAprep spin
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Miniprep kit (Qiagen, Valencia, CA) according to manufacturer’s directions. Plasmid
recovery was confirmed using a 1% agarose gel. Plasmids were sent to SeqWright Inc.
(Houston, TX) for sequencing using T7, T4, and internal TCRV primers (Table 10, see
page 102). Sequencing files were edited using Sequencher (GeneCodes, Ann Arbor,
MI) and BLAST was used for gene identification.
Addition of restriction sites
Following sequence identification of the plasmid insert as TCRV nucleocapsid,
virus specific primers were designed with restriction enzyme sites flanking each primer
(Table 11, see page 102). The forward primer was designed with an EcoRI site and the
reverse primer was designed with a XhoI site. Primer design was carefully performed to
ensure that the amplified portion of the nucleocapsid could be inserted into the
expression vector in the correct reading frame for protein expression. PCR was
performed on TOPO plasmids that contained the TCRV nucleocapsid. PCR products
containing the EcoRI and XhoI overhangs were cloned back into TOPO cloning vector
and used to transform One Shot Chemically competent E. coli cells (Invitrogen,
Carlsbad, CA). Plasmid purifications were performed as described earlier, and plasmids
were sent out for sequencing to confirm the presence of the restriction sites on either
side of the TCRV nucleocapsid fragment.
Sub-cloning Into pET-21b
TOPO plasmids containing the TCRV nucleocapsid gene insert and pET-21b
plasmids (Novagen, Sandiego, CA) were digested at 37°C for 4 hours using EcoRI and
XhoI restriction enzymes in Buffer H (Promega, Madison, WI). Digests were resolved on
a 1% agarose gel and gel extraction was performed using Wizard SV Gel and PCR
Cleanup System (Promega, Madison, WI). Gel extracted digests were then ligated at
4°C overnight using T4 ligase (Promega, Madison, WI). Ligations were then used to
transform competent NovaBlue E. coli cells (Novagen, San Diego, CA). Bacterial colony
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screens and plasmid minipreps were performed as previously described. Plasmids were
sent to SeqWright Inc. (Houston, TX) for DNA sequencing using T7, T7 terminator, and
internal TCRV primers.
Results
A 1588 bp fragment of the TCRV nucleocapsid gene (nt 1716-3303) was
successfully cloned into TOPO TA cloning vector with EcoRI and XhoI restriction sites
flanking it. Sequence analysis showed that EcoRI and XhoI restriction sites are flanking
the TCRV gene, and BLAST searches have confirmed that the gene insert that is
present in TOPO TA is TCRV. It is believed that the TCRV nucleocapsid fragment has
been successfully cloned into the pET-21b expression vector in the correct reading
frame needed for protein expression with an attached his-tag, but confirmation by
sequence analysis has not been successful. Plasmid purification from NovaBlue E. coli
cells transformed with pET-21b vector yield low concentrations of plasmid. The
concentration of the plasmid purification preparations has been so low that subsequent
sequencing reactions have been unsuccessful.
Discussion
pET-21b
The expression vector, pET-21b, is ideal for expressing and purifying a portion of
the TCRV nucleocapsid protein for several reasons. First, it has ampicillin and
kanamyacin resistance genes, which allow for selection of bacterial colonies that have
been transformed with the vector. This helps to ensure that bacterial colonies have
been transformed with the expression vector and the TCRV gene insert. Also, pET-21b
has a Lac operon encoded in its sequence, which allows for stimulation of protein
expression using isopropyl β-D-1-thiogalactopyranoside (IPTG). IPTG is molecularly
similar to allalactose. Treatment of bacterial cultures with IPTG causes stimulation of
the Lac operon and thus the expression of gene fragments that have been cloned into
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pET-21b. The pET-21b plasmid also encodes a 6x histidine tag (His-tag) that will be
added to the C-terminus of the TCRV polypeptide during protein expression. Correct
expression of the protein with the attached His-tag requires that the gene fragment be
inserted into the vector in the correct reading frame. After protein expression, the TCRV
nucleocapsid protein will have a C-terminal His-tag attached. This His-tag will allow for
the purification of the TCRV antigen using column chromatography. These
characteristics make the pET-21b vector ideal for expression of the TCRV antigen.
Problems that could possibly occur while trying to express the TCRV antigen
include bacterial cell culture complications yielding low concentration of the expressed
antigen, or that the insert is not in the correct reading frame for expression with an
attached His-tag. One possible limitation to this approach include that the TCRV insert
may be too large and could be problematic when expressing the protein. If this were the
case, it might be necessary to identify the specific (smaller) fragment of the TCRV
nucleocapsid that is the immunodominate epitope and only express that portion of the
protein. A second limitation to this approach is that the expressed TCRV nucleocapsid
antigen could possibly cross-react with antibodies that are specific for other closely
related arenaviruses. Analysis of antibody binding capability would be necessary to
determine if this is a problem.
Current status of the project
Sequence analysis has confirmed the successful cloning of a 1588 bp fragment
of the TCRV nucleocapsid gene into TOPO TA cloning vector with EcoRI and XhoI
restriction sites flanking it. It is believed that this fragment has been successfully cloned
into pET-21b expression vector, but confirmation has not been obtained. A
concentration of 200 ng/µl of DNA is required for quality DNA sequencing and we
believe that previous attempts to sequence pET-21b vector have not been successful
because it is a low-copy vector. Plasmid purifications using NovaBlue cells and pET-21b

100
do not yield sufficient concentrations of plasmid to allow DNA sequencing. It is likely that
Maxiprep plasmid purification or a precipitation reaction of Miniprep plasmid purification
yields may allow the acquisition of high enough concentrations to perform DNA
sequencing.
Strategies for producing and
purifying the antigen
Once sequence analysis confirms that the entire TCRV nucleocapsid insert is
present in the expression vector, in the correct reading frame, without any deletions, it
will be used to transform BL21 expression E. coli cells (Novagen, San Diego, CA). BL21
cells will be used for expression of the protein, and the antigen will be purified using
column chromatography. These methods will be adapted from previously described
methods [16, 110, 220]. Briefly, BL21 cultures will be treated with IPTG to stimulate
protein expression from the Lac operon. Cells will then be lysed and extractions will be
collected. Extractions will then be filtered by column chromatography using a cobalt
column. This is also known as metal chelate-affinity chromatography [220]. Purified
fractions will then be subjected to Western Blot analysis using anti-TCRV mouse ascites
fluid as the primary antibody, and an anti-mouse alkaline phosphatase-conjugated
antibody as the secondary antibody.
The purified fragment of the TCRV nucleocapsid will then be used as the antigen
that is coated on 96-well polyvinyl chloride plates and used for the detection of TCRVspecific antibodies in mammalian serum samples. A rapid field test similar to the one
described by Schountz et al. [16], will be developed. This will include 96 well polyvinyl
chloride plates coated with the TCRV antigen and blocked using porcine gelatin prior to
performing work in the field. Serum samples from wild-caught mammals will be added to
the wells, and staphylococcal protein-A and streptococcal protein-G horseradish
peroxidase (protein A/G-HRP) conjugate will be used to detect the presence of anti-
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TCRV specific antibodies. Results will be visualized with the addition of activated ABTS
substrate. Washes will be performed using PBS with 0.5% Tween-20 [16].
The immunoassay proposed here will likely take an hour to complete in the field
whereas other similar assays can take as long as 3 to 5 hours [16, 182, 216]. The use of
protein A/G-HRP makes the use of an anti-bat or other species-specific antibody
unnecessary. It has been found that protein-A and protein-G HRP conjugates have the
ability to bind the Fc regions of antibodies of a number of different mammalian species
and can detect immunoglobulin M (IgM), IgA, and high affinity IgG [110]. These
characteristics make this immunoassay ideal for screening wild mammals for TCRVspecific antibody.
The cloning a large fragment of the TCRV nucleocapsid into TOPO-TA cloning
vector has been accomplished and it is believed that it has now been ligated into pET21b expression vector. It is also believed that DNA sequence analysis will soon reveal
that the TCRV nucleocapsid is in correct reading frame for protein synthesis with an
attached 6x His-tag on the C-terminus of the protein. It is hypothesized that protein
expression and purification will be possible. Tacaribe virus has an unknown natural host
and it is likely that this antigen can be used in a rapid field immunoassay to screen
mammals for TCRV-specific antibody. Due to the broad species specificity of this assay
and the ease with which it might be used in the field, it is believed that it could be
instrumental in identifying the natural reservoir of Tacaribe virus.
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Table 9. Primer sequences used to amplify a fragment of the TCRV Nucleocapsid. Sequences listed 5’ to 3’. Reverse
primer sequence was found in Bowen et al., 1996.
Forward TCRV PCR primer

Reverse TCRV PCR primer

AGTCTTACAGCTCACAGTGC

CGCACAGTGGATCCTAGGC

Size
(bp)
1800

Table 10. Primer sequences used in DNA sequencing of internal fragments of the TCRV nucleocapsid. Sequences
listed 5’ to 3’.
Forward TCRV PCR primer

Reverse TCRV PCR primer

AATTTGCGATCGAGAGCCTA

AGCTCATCCCAAACCATGAG

Size
(bp)
316

Table 11. TCRV primers used for the addition of restriction sites. Sequences listed 5’ to 3’. Restriction sites are
underlined in each primer.
Forward TCRV PCR primer

Reverse TCRV PCR primer

CCGAATTCGGGATTGAGTCAATTCACC

TACTCGAGTAGTTCTCCACTCATGGC

Size
(bp)
1595
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CHAPTER VI
CONCLUSONS
Bats comprise one of the largest groups of known species of mammals and they
have tremendous ecological importance. The general biology and ecology of bats has
been extensively studied, yet many aspects of bat biology are still poorly understood. In
the past decade, bats have been recognized as reservoirs of potential reservoirs of
important human and veterinary pathogens. However, virtually nothing is known about
the immune systems or immune responses of bats. This is a significant gap in the
knowledge of bat biology.
Only recently have researchers begun to investigate this aspect of bat biology.
In many instances, it appears that bats may become persistently infected with viruses
without developing disease. This type of interaction is commonly seen between viruses
and the natural reservoir. Spillover infections with many of the same viruses into human
other mammalian populations can cause serious disease, including the South American
hemorrhagic fevers. Not only may research on bat immunology help to fill the gap in
knowledge that exists in bat biology, it could also provide insights to the mechanisms by
which viruses are able to evade sterilizing immune responses, and persist in bat hosts
without causing pathology. If researchers could identify the underlying mechanisms by
which this interaction is accomplished, it could offer medically important information
about possible treatments for human infections.
Another important reason for the examination of immune systems and immune
responses of bats is the possible benefit this information could provide for bat
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populations. Some interactions between bats and microorganisms can cause serious
and fatal disease, and in many cases, this can be devastating to bat populations. It is
possible that an understanding of bat immune systems and bat-microbe interactions
could offer potential for solutions to this problem as well.
The work presented in this dissertation represents a significant step toward
characterizing bat immune systems and the interactions that occur between bats and
viruses. The results from cloning and characterization of bat cytokine genes have
indicated that the cytokine genes of Seba’s short-tailed fruit bats are highly conserved
with respect to orthologous mammalian sequences. The high level of identity and
similarity that was observed is likely an indication that the genetics of bat immune
systems are very similar to the genetics of other mammalian immune systems. This
could indicate that the regulation of immune genes during infection could contribute to
the ability of bats to become persistently infected without developing disease. It is
suggested that further research focus on examining the regulation of bat immune genes
during infection. In vitro and in vivo experimental infections could be used to examine
the modulation of immune genes during infection.
The results from experimental infections of Jamaican fruit bats with Tacaribe
virus have indicated that Jamaican fruit bats do not become persistently infected with
TCRV. Instead, it was found that high dose inoculations resulted in acute infections with
severe and fatal disease, while low dose inoculations led to no disease with eventual
virus clearance. These findings have led the conclusion that Jamaican fruit bats are
likely not the reservoir of TCRV
It is speculated that when Downs et al. first isolated TCRV from Artibeus bats
[33], infections were incidental. Due to the failure of an extensive search to identify a
rodent reservoir of TCRV on the islands of Trinidad and Tobago [33], it is suggested that
Artibeus bats came in contact with the virus in another location. Artibeus bats are found
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in tropical regions of South America, the Caribbean Islands, the Florida Keys, and
Central America [175]. Trinidad, where TCRV was first isolated is approximately 10 km
from Venezuela. This distance is within the flight range of Artibeus bats [211]. It is
possible that Jamaican fruit bats from which TCRV was first isolated may have been
infected with TCRV in Venezuela and introduced the virus to the Antillean islands before
experiencing pathological symptoms.
It could also be speculated that the natural reservoir of TCRV is a rodent species.
This would make sense in light of the fact that all arenaviruses, for which the hosts are
known, are rodent-borne viruses. More specifically, the known reservoirs of Junín,
Machupo, and Guanarito viruses, (Calomys musculinus, Calomys callosus and
Zygodontomys brevicauda respectively), are all rodents in the subfamily Sigmodontinae
[71, 125, 170]. These rodents are known as the New World cricetines [221]. There are
several genera of these rodents located in the areas where Artibeus bats are also
located. There are five genera of New World cricetines that inhabit the Republic of
Trinidad and Tobago. These are Oryzomys, Akodon, Zygodontomys, Rhipidomys, and
Nectomys [221]. There are also 20 genera New World cricetines that inhabit areas of
Venezuela. These include Oryzomys, Akodon, Zygodontomys, Rhipidomys Nectomys,
Neacomys, Aepeomys, Thomasomys, Neusticomys, Ichthyomys, Calomys, Holochilus,
Sigmodon, Chilomys, Melanomys, Microorozomys, Oligorizomys, Sigmodontomys, and
Oecomys [221]. It is suggested that Artibeus bats came in contact with rodents or
infectious secretions from rodents in Venezuela.
When considering the question of how bats might have come in contact with
rodents or their secretions, it is suggested that a possible source could be rodents in the
genus Oecomys. These rodents are found in Venezuela and are called the arboreal rice
rats, and as the name implies, they live in trees [221]. While some Artibeus bats roost in
caves, others utilize foliage or cavities in trees as a roost sites. It is possible that bats
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could possibly be exposed to TCRV when roosting in close proximity to arboreal rice
rats. While this is one possible route of exposure, it is feasible that bats could be coming
in contact with other infected rodents.
Due to the lack of evidence of a reservoir of TCRV in Trinidad and Tobago, it is
suspected that the natural reservoir of TCRV could be found in Venezuela. Venezuela is
the closest country to Trinidad and Tobago and has a large number of mammalian
species that inhabit it [221]. It is suggested that a serologic survey of mammals
(especially rodents) in areas of Venezuela where Artibeus bats could have come in
contact with TCRV, should be conducted. It may also be advantageous to conduct
another serologic survey of mammals in the Antillean islands to ensure that nothing was
previously missed.
Although the interaction between TCRV and Jamaican fruit bats appears to not
be that of a virus and a natural reservoir, this study has provided important information
about the interaction between TCRV and Jamaican fruit bats. The findings of this
research project represent an important development in the world of arenaviruses, as it
was previously believed that TCRV was the only arenavirus, for which the host is known,
to have a non-rodent host. Evidence thus far supports that development of a rapid field
immunoassay that can be used to detect TCRV-specific antibody will soon be available.
The rapid field immunoassay may be useful in the identification of the true reservoir of
TCRV.
Other future work that is recommended is the exploration of TCRV infection in
Jamaican fruit bats as a disease model for South American hemorrhagic fevers. Due to
the fact that Jamaican fruit bats infected with TCRV developed symptoms such as
tremors, that are very similar to the symptoms experienced by humans infected with
Junín virus, it is possible that Jamaican fruit bats could serve as an animal model for
SAHF [172]. An animal model of SAHF could provide the opportunity to evaluate how
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disease progresses in human cases, and offer the potential to identify more effective
treatment options.
While many researchers fear that the identification and examination of bats as
reservoirs may lead to the persecution of bats, it seems irrational to ignore such a large
portion of bat biology and ecology. This fear of persecution and eradication of bats may
be founded on real concerns and care must be taken with such a controversial topic. A
balance must be found between examining the immune systems and immune responses
of bats with bat conservation. Possible solutions to this problem include closely
integrating the fields of bat ecology, conservation, disease ecology, and microbiology, as
well as increased education of the general public on the ecological and economic
importance of bats. Bats engage in many important activities including seed dispersal,
pollination, and insect control, and thus, it must not be forgotten that bats have an
enormous amount of ecologic significance. It must be remembered that conservation of
bat species is necessary and that eradication of bat species could be counterproductive.
However, it is important for immunologic research in bats to continue, as it is important
to the comprehensive understanding of bat biology, and could offer potentially
advantageous information in relation to the management of infectious disease in humans
and bats.
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